| Year |
Citation |
Score |
| 2024 |
Moujaes F, Ji JL, Rahmati M, Burt JB, Schleifer C, Adkinson BD, Savic A, Santamauro N, Tamayo Z, Diehl C, Kolobaric A, Flynn M, Rieser N, Fonteneau C, Camarro T, ... ... Krystal JH, et al. Ketamine induces multiple individually distinct whole-brain functional connectivity signatures. Elife. 13. PMID 38629811 DOI: 10.7554/eLife.84173 |
0.507 |
|
| 2024 |
Chekroud AM, Hawrilenko M, Loho H, Bondar J, Gueorguieva R, Hasan A, Kambeitz J, Corlett PR, Koutsouleris N, Krumholz HM, Krystal JH, Paulus M. Illusory generalizability of clinical prediction models. Science (New York, N.Y.). 383: 164-167. PMID 38207039 DOI: 10.1126/science.adg8538 |
0.641 |
|
| 2023 |
Berkovitch L, Lee K, Ji JL, Helmer M, Rahmati M, Demšar J, Kraljič A, Matkovič A, Tamayo Z, Murray JD, Repovš G, Krystal JH, Martin WJ, Fonteneau C, Anticevic A. A common symptom geometry of mood improvement under sertraline and placebo associated with distinct neural patterns. Medrxiv : the Preprint Server For Health Sciences. PMID 38168378 DOI: 10.1101/2023.12.15.23300019 |
0.532 |
|
| 2023 |
Krystal JH, Kaye AP, Jefferson S, Girgenti MJ, Wilkinson ST, Sanacora G, Esterlis I. Ketamine and the neurobiology of depression: Toward next-generation rapid-acting antidepressant treatments. Proceedings of the National Academy of Sciences of the United States of America. 120: e2305772120. PMID 38011560 DOI: 10.1073/pnas.2305772120 |
0.502 |
|
| 2023 |
Ward EJ, Fragala MS, Birse CE, Hawrilenko M, Smolka C, Ambwani G, Brown M, Krystal JH, Corlett PR, Chekroud A. Assessing the impact of a comprehensive mental health program on frontline health service workers. Plos One. 18: e0294414. PMID 37988363 DOI: 10.1371/journal.pone.0294414 |
0.635 |
|
| 2023 |
Lee K, Ji JL, Fonteneau C, Berkovitch L, Rahmati M, Pan L, Repovš G, Krystal JH, Murray JD, Anticevic A. Human brain state dynamics reflect individual neuro-phenotypes. Biorxiv : the Preprint Server For Biology. PMID 37790400 DOI: 10.1101/2023.09.18.557763 |
0.478 |
|
| 2023 |
Krystal JH, Preller KH, Corlett PR, Anticevic A, Kaye AP. Psychedelics and the neurobiology of meaningfulness. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. PMID 37730161 DOI: 10.1016/j.bpsc.2023.09.003 |
0.517 |
|
| 2023 |
Abi-Dargham A, Moeller SJ, Ali F, DeLorenzo C, Domschke K, Horga G, Jutla A, Kotov R, Paulus MP, Rubio JM, Sanacora G, Veenstra-VanderWeele J, Krystal JH. Candidate biomarkers in psychiatric disorders: state of the field. World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 22: 236-262. PMID 37159365 DOI: 10.1002/wps.21078 |
0.531 |
|
| 2023 |
Shinn M, Hu A, Turner L, Noble S, Preller KH, Ji JL, Moujaes F, Achard S, Scheinost D, Constable RT, Krystal JH, Vollenweider FX, Lee D, Anticevic A, Bullmore ET, et al. Functional brain networks reflect spatial and temporal autocorrelation. Nature Neuroscience. PMID 37095399 DOI: 10.1038/s41593-023-01299-3 |
0.462 |
|
| 2022 |
Kohler CG, Wolf DH, Abi-Dargham A, Anticevic A, Cho YT, Fonteneau C, Gil R, Girgis RR, Gray DL, Grinband J, Javitch JA, Kantrowitz JT, Krystal JH, Lieberman JA, Murray JD, et al. Illness Phase as a Key Assessment and Intervention Window for Psychosis. Biological Psychiatry Global Open Science. 3: 340-350. PMID 37519466 DOI: 10.1016/j.bpsgos.2022.05.009 |
0.516 |
|
| 2022 |
Rhee TG, Shim SR, Forester BP, Nierenberg AA, McIntyre RS, Papakostas GI, Krystal JH, Sanacora G, Wilkinson ST. Efficacy and Safety of Ketamine vs Electroconvulsive Therapy Among Patients With Major Depressive Episode: A Systematic Review and Meta-analysis. Jama Psychiatry. PMID 36260324 DOI: 10.1001/jamapsychiatry.2022.3352 |
0.479 |
|
| 2022 |
Bondar J, Babich Morrow C, Gueorguieva R, Brown M, Hawrilenko M, Krystal JH, Corlett PR, Chekroud AM. Clinical and Financial Outcomes Associated With a Workplace Mental Health Program Before and During the COVID-19 Pandemic. Jama Network Open. 5: e2216349. PMID 35679044 DOI: 10.1001/jamanetworkopen.2022.16349 |
0.616 |
|
| 2022 |
Averill LA, Jiang L, Purohit P, Coppoli A, Averill CL, Roscoe J, Kelmendi B, De Feyter HM, de Graaf RA, Gueorguieva R, Sanacora G, Krystal JH, Rothman DL, Mason GF, Abdallah CG. Prefrontal Glutamate Neurotransmission in PTSD: A Novel Approach to Estimate Synaptic Strength in Vivo in Humans. Chronic Stress (Thousand Oaks, Calif.). 6: 24705470221092734. PMID 35434443 DOI: 10.1177/24705470221092734 |
0.465 |
|
| 2022 |
Cho YT, Moujaes F, Schleifer CH, Starc M, Ji JL, Santamauro N, Adkinson B, Kolobaric A, Flynn M, Krystal JH, Murray JD, Repovs G, Anticevic A. Reward and loss incentives improve spatial working memory by shaping trial-by-trial posterior frontoparietal signals. Neuroimage. 254: 119139. PMID 35346841 DOI: 10.1016/j.neuroimage.2022.119139 |
0.467 |
|
| 2022 |
Holmes SE, Finnema SJ, Naganawa M, DellaGioia N, Holden D, Fowles K, Davis M, Ropchan J, Emory P, Ye Y, Nabulsi N, Matuskey D, Angarita GA, Pietrzak RH, Duman RS, ... ... Krystal JH, et al. Imaging the effect of ketamine on synaptic density (SV2A) in the living brain. Molecular Psychiatry. PMID 35165397 DOI: 10.1038/s41380-022-01465-2 |
0.528 |
|
| 2022 |
Averill LA, Averill CL, Gueorguieva R, Fouda S, Sherif M, Ahn KH, Ranganathan M, D'Souza DC, Southwick SM, Sanacora G, Duman RS, Krystal JH, Abdallah CG. mTORC1 inhibitor effects on rapid ketamine-induced reductions in suicidal ideation in patients with treatment-resistant depression. Journal of Affective Disorders. PMID 35101523 DOI: 10.1016/j.jad.2022.01.104 |
0.509 |
|
| 2021 |
Lam NH, Borduqui T, Hallak J, Roque A, Anticevic A, Krystal JH, Wang XJ, Murray JD. Effects of Altered Excitation-Inhibition Balance on Decision Making in a Cortical Circuit Model. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 34887320 DOI: 10.1523/JNEUROSCI.1371-20.2021 |
0.484 |
|
| 2021 |
Abi-Dargham A, Javitch JA, Slifstein M, Anticevic A, Calkins ME, Cho YT, Fonteneau C, Gil R, Girgis R, Gur RE, Gur RC, Grinband J, Kantrowitz J, Kohler C, Krystal J, et al. Dopamine D1R Receptor Stimulation as a Mechanistic Pro-cognitive Target for Schizophrenia. Schizophrenia Bulletin. PMID 34423843 DOI: 10.1093/schbul/sbab095 |
0.506 |
|
| 2021 |
Burt JB, Preller KH, Demirtas M, Ji JL, Krystal JH, Vollenweider FX, Anticevic A, Murray JD. Transcriptomics-informed large-scale cortical model captures topography of pharmacological neuroimaging effects of LSD. Elife. 10. PMID 34313217 DOI: 10.7554/eLife.69320 |
0.508 |
|
| 2021 |
Haeny AM, Gueorguieva R, Jackson A, Morean ME, Krishnan-Sarin S, DeMartini KS, Pearlson GD, Anticevic A, Krystal JH, O'Malley SS. Individual differences in the associations between risk factors for alcohol use disorder and alcohol use-related outcomes. Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors. PMID 34110841 DOI: 10.1037/adb0000733 |
0.48 |
|
| 2021 |
DeMartini KS, Gueorguieva R, Pearlson G, Krishnan-Sarin S, Anticevic A, Ji LJ, Krystal JH, O'Malley SS. Mapping Data-Driven Individualized Neurobehavioral Phenotypes in Heavy Alcohol Drinkers. Alcoholism, Clinical and Experimental Research. PMID 33605439 DOI: 10.1111/acer.14580 |
0.498 |
|
| 2020 |
Hillmer AT, Angarita GA, Esterlis I, Anderson JM, Nabulsi N, Lim K, Ropchan J, Carson RE, Krystal JH, Malley SSO, Cosgrove KP. Longitudinal imaging of metabotropic glutamate 5 receptors during early and extended alcohol abstinence. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 32919411 DOI: 10.1038/S41386-020-00856-9 |
0.308 |
|
| 2020 |
Abdallah CG, Krystal JH. Ketamine and rapid acting antidepressants: Are we ready to cure, rather than treat depression? Behavioural Brain Research. 390: 112628. PMID 32407817 DOI: 10.1016/J.Bbr.2020.112628 |
0.324 |
|
| 2020 |
Kantrowitz JT, Grinband J, Goff DC, Lahti AC, Marder SR, Kegeles LS, Girgis RR, Sobeih T, Wall MM, Choo TH, Green MF, Yang YS, Lee J, Horga G, Krystal JH, et al. Proof of mechanism and target engagement of glutamatergic drugs for the treatment of schizophrenia: RCTs of pomaglumetad and TS-134 on ketamine-induced psychotic symptoms and pharmacoBOLD in healthy volunteers. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 32403118 DOI: 10.1038/S41386-020-0706-Z |
0.319 |
|
| 2020 |
Krystal JH, Charney DS, Duman RS. A New Rapid-Acting Antidepressant. Cell. 181: 7. PMID 32243798 DOI: 10.1016/J.Cell.2020.02.033 |
0.453 |
|
| 2020 |
Preller KH, Duerler P, Burt JB, Ji JL, Adkinson B, Stämpfli P, Seifritz E, Repovš G, Krystal JH, Murray JD, Anticevic A, Vollenweider FX. Psilocybin Induces Time-Dependent Changes in Global Functional Connectivity. Biological Psychiatry. PMID 32111343 DOI: 10.1016/J.Biopsych.2019.12.027 |
0.529 |
|
| 2020 |
Abdallah CG, Averill LA, Gueorguieva R, Goktas S, Purohit P, Ranganathan M, Sherif M, Ahn KH, D'Souza DC, Formica R, Southwick SM, Duman RS, Sanacora G, Krystal JH. Modulation of the antidepressant effects of ketamine by the mTORC1 inhibitor rapamycin. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 32092760 DOI: 10.1038/S41386-020-0644-9 |
0.558 |
|
| 2020 |
Krystal JH, Nestler EJ, Picciotto MR. Ronald S. Duman, Ph.D. (1954-2020). Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 32076104 DOI: 10.1038/S41386-020-0642-Y |
0.365 |
|
| 2020 |
McCutcheon RA, Krystal JH, Howes OD. Dopamine and glutamate in schizophrenia: biology, symptoms and treatment. World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 19: 15-33. PMID 31922684 DOI: 10.1002/Wps.20693 |
0.33 |
|
| 2020 |
Nestler EJ, Krystal JH. Ronald S. Duman (1954–2020) Neuron. 105: 769-770. DOI: 10.1016/J.Neuron.2020.02.018 |
0.369 |
|
| 2020 |
Nemati S, Akiki T, Ju Y, Averill C, Fouda S, Dutta A, Mckie S, Krystal J, Deakin B, Averill L, Abdallah C. A Shift in Executive Connectivity Predates and Predicts Response to Treatment in Major Depressive Disorder Biological Psychiatry. 87. DOI: 10.1016/J.Biopsych.2020.02.294 |
0.315 |
|
| 2019 |
Suzuki S, Mell MM, O'Malley SS, Krystal JH, Anticevic A, Kober H. Regulation of Craving and Negative Emotion in Alcohol Use Disorder. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. PMID 31892465 DOI: 10.1016/J.Bpsc.2019.10.005 |
0.551 |
|
| 2019 |
Dennis EL, Disner SG, Fani N, Salminen LE, Logue M, Clarke EK, Haswell CC, Averill CL, Baugh LA, Bomyea J, Bruce SE, Cha J, Choi K, Davenport ND, Densmore M, ... ... Krystal J, et al. Altered white matter microstructural organization in posttraumatic stress disorder across 3047 adults: results from the PGC-ENIGMA PTSD consortium. Molecular Psychiatry. PMID 31857689 DOI: 10.1038/S41380-019-0631-X |
0.323 |
|
| 2019 |
Haeny AM, Gueorguieva R, Morean ME, Krishnan-Sarin S, DeMartini KS, Pearlson GD, Anticevic A, Krystal JH, O'Malley SS. The Association of Impulsivity and Family History of Alcohol Use Disorder on Alcohol Use and Consequences. Alcoholism, Clinical and Experimental Research. PMID 31693193 DOI: 10.1111/Acer.14230 |
0.531 |
|
| 2019 |
Chen MH, Cheng CM, Gueorguieva R, Lin WC, Li CT, Hong CJ, Tu PC, Bai YM, Tsai SJ, Krystal JH, Su TP. Maintenance of antidepressant and antisuicidal effects by D-cycloserine among patients with treatment-resistant depression who responded to low-dose ketamine infusion: a double-blind randomized placebo-control study. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 31421635 DOI: 10.1038/S41386-019-0480-Y |
0.321 |
|
| 2019 |
Ji JL, Diehl C, Schleifer C, Tamminga CA, Keshavan MS, Sweeney JA, Clementz BA, Hill SK, Pearlson G, Yang G, Creatura G, Krystal JH, Repovs G, Murray J, Winkler A, et al. Schizophrenia Exhibits Bi-directional Brain-Wide Alterations in Cortico-Striato-Cerebellar Circuits. Cerebral Cortex (New York, N.Y. : 1991). PMID 31157363 DOI: 10.1093/Cercor/Bhy306 |
0.687 |
|
| 2019 |
Abdallah CG, Roache JD, Averill LA, Young-McCaughan S, Martini B, Gueorguieva R, Amoroso T, Southwick SM, Guthmiller K, López-Roca AL, Lautenschlager K, Mintz J, Litz BT, Williamson DE, Keane TM, ... ... Krystal JH, et al. Repeated ketamine infusions for antidepressant-resistant PTSD: Methods of a multicenter, randomized, placebo-controlled clinical trial. Contemporary Clinical Trials. PMID 30999057 DOI: 10.1016/J.Cct.2019.04.009 |
0.307 |
|
| 2019 |
Holmes SE, Scheinost D, Finnema SJ, Naganawa M, Davis MT, DellaGioia N, Nabulsi N, Matuskey D, Angarita GA, Pietrzak RH, Duman RS, Sanacora G, Krystal JH, Carson RE, Esterlis I. Lower synaptic density is associated with depression severity and network alterations. Nature Communications. 10: 1529. PMID 30948709 DOI: 10.1038/S41467-019-09562-7 |
0.556 |
|
| 2019 |
Duman RS, Sanacora G, Krystal JH. Altered Connectivity in Depression: GABA and Glutamate Neurotransmitter Deficits and Reversal by Novel Treatments. Neuron. 102: 75-90. PMID 30946828 DOI: 10.1016/J.Neuron.2019.03.013 |
0.596 |
|
| 2019 |
Fleming LM, Javitt DC, Carter CS, Kantrowitz JT, Girgis RR, Kegeles LS, Ragland JD, Maddock RJ, Lesh TA, Tanase C, Robinson J, Potter WZ, Carlson M, Wall MM, Choo TH, ... ... Krystal JH, et al. A multicenter study of ketamine effects on functional connectivity: Large scale network relationships, hubs and symptom mechanisms. Neuroimage. Clinical. 22: 101739. PMID 30852397 DOI: 10.1016/J.Nicl.2019.101739 |
0.369 |
|
| 2019 |
Krystal JH, Abdallah CG, Sanacora G, Charney DS, Duman RS. Ketamine: A Paradigm Shift for Depression Research and Treatment. Neuron. 101: 774-778. PMID 30844397 DOI: 10.1016/J.Neuron.2019.02.005 |
0.632 |
|
| 2019 |
Tang Y, Zhou Q, Chang M, Chekroud A, Gueorguieva R, Jiang X, Zhou Y, He G, Rowland M, Wang D, Fu S, Yin Z, Leng H, Wei S, Xu K, ... ... Krystal JH, et al. Altered functional connectivity and low-frequency signal fluctuations in early psychosis and genetic high risk. Schizophrenia Research. PMID 30685394 DOI: 10.1016/J.Schres.2018.12.041 |
0.693 |
|
| 2019 |
Yoon G, Petrakis IL, Krystal JH. Association of Combined Naltrexone and Ketamine With Depressive Symptoms in a Case series of Patients With Depression and Alcohol Use Disorder. Jama Psychiatry. PMID 30624551 DOI: 10.1001/Jamapsychiatry.2018.3990 |
0.333 |
|
| 2019 |
Burt J, Preller K, Demirtas M, Ji JL, Krystal J, Vollenweider F, Anticevic A, Murray J. S175. Large-Scale Model of Human Cortex Captures LSD-Induced Functional Alterations via HTR2A-Mediated Neural Gain Modulation Biological Psychiatry. 85. DOI: 10.1016/J.Biopsych.2019.03.926 |
0.531 |
|
| 2019 |
Moujaes F, Preller K, Vollenweider F, Schleifer C, Ji JL, Adkinson B, Kolobaric A, Flynn M, Fineberg S, Krystal J, Repovs G, Santamauro N, Morgan P, Savic A, Cho Y, et al. S159. NMDA Receptor Antagonism Effects on Delayed Spatial Working Memory and Distraction in Comparison With Schizophrenia Biological Psychiatry. 85: S358. DOI: 10.1016/J.Biopsych.2019.03.910 |
0.554 |
|
| 2019 |
Moujaes F, Schleifer C, Ji L, Adkinson B, Kolobaric A, Flynn M, Fineberg S, Krystal J, Repovs G, Cho Y, Santamauro N, Morgan P, Savic A, Murray J, Anticevic A. F195. NMDAR Antagonism via Ketamine Differentially Modulates Thalamic Versus Hippocampal Brain-Wide Functional Connectivity Biological Psychiatry. 85: S289. DOI: 10.1016/J.Biopsych.2019.03.732 |
0.523 |
|
| 2019 |
Cho Y, Schleifer C, Moujaes F, Starc M, Ji JL, Santamauro N, Adkinson B, Kolobaric A, Flynn M, Krystal J, Murray J, Repovs G, Anticevic A. T193. Monetary Incentives Shape Behavioral and Neural Precision of Spatial Working Memory Biological Psychiatry. 85: S204-S205. DOI: 10.1016/J.Biopsych.2019.03.516 |
0.502 |
|
| 2019 |
Kolobaric A, Anticevic A, Hu X, Xiao Y, Hu J, Li F, Bi F, Cole M, Savic A, Yang G, Repovs G, Murray J, Wang X, Huang X, Lui S, ... Krystal J, et al. T174. Examining the Neurobiological Progression of Early Course Schizophrenia Biological Psychiatry. 85: S196-S197. DOI: 10.1016/J.Biopsych.2019.03.497 |
0.661 |
|
| 2019 |
Holmes S, Scheinost D, Finnema S, Naganawa M, Davis M, DellaGioia N, Nabulsi N, Matuskey D, Angarita G, Pietrzak R, Duman R, Sanacora G, Krystal J, Carson R, Esterlis I. 142. Synaptic Density Alterations are Associated With Depression Severity and Network Alterations Biological Psychiatry. 85. DOI: 10.1016/J.Biopsych.2019.03.156 |
0.523 |
|
| 2018 |
Chekroud AM, Loho H, Paulus M, Krystal JH. PTSD and the War of Words. Chronic Stress (Thousand Oaks, Calif.). 2: 2470547018767387. PMID 32440582 DOI: 10.1177/2470547018767387 |
0.654 |
|
| 2018 |
Averill CL, Averill LA, Wrocklage KM, Scott JC, Akiki TJ, Schweinsburg B, Southwick SM, Krystal JH, Abdallah CG. Altered White Matter Diffusivity of the Cingulum Angular Bundle in Posttraumatic Stress Disorder. Molecular Neuropsychiatry. 4: 75-82. PMID 30397595 DOI: 10.1159/000490464 |
0.602 |
|
| 2018 |
Akiki TJ, Averill CL, Wrocklage KM, Scott JC, Averill LA, Schweinsburg B, Alexander-Bloch A, Martini B, Southwick SM, Krystal JH, Abdallah CG. Topology of brain functional connectivity networks in posttraumatic stress disorder. Data in Brief. 20: 1658-1675. PMID 30364328 DOI: 10.1016/J.Dib.2018.08.198 |
0.627 |
|
| 2018 |
Preller KH, Burt JB, Ji JL, Schleifer CH, Adkinson BD, Stämpfli P, Seifritz E, Repovs G, Krystal JH, Murray JD, Vollenweider FX, Anticevic A. Changes in global and thalamic brain connectivity in LSD-induced altered states of consciousness are attributable to the 5-HT2A receptor. Elife. 7. PMID 30355445 DOI: 10.7554/Elife.35082 |
0.549 |
|
| 2018 |
Chekroud SR, Gueorguieva R, Zheutlin AB, Paulus M, Krumholz HM, Krystal JH, Chekroud AM. Physical activity and mental health - Author's reply. The Lancet. Psychiatry. PMID 30245184 DOI: 10.1016/S2215-0366(18)30354-7 |
0.638 |
|
| 2018 |
Abdallah CG, Averill LA, Akiki TJ, Raza M, Averill CL, Gomaa H, Adikey A, Krystal JH. The Neurobiology and Pharmacotherapy of Posttraumatic Stress Disorder. Annual Review of Pharmacology and Toxicology. PMID 30216745 DOI: 10.1146/Annurev-Pharmtox-010818-021701 |
0.313 |
|
| 2018 |
Chekroud SR, Gueorguieva R, Zheutlin AB, Paulus M, Krumholz HM, Krystal JH, Chekroud AM. Association between physical exercise and mental health in 1·2 million individuals in the USA between 2011 and 2015: a cross-sectional study. The Lancet. Psychiatry. PMID 30099000 DOI: 10.1016/S2215-0366(18)30227-X |
0.642 |
|
| 2018 |
Abdallah CG, De Feyter HM, Averill LA, Jiang L, Averill CL, Chowdhury GMI, Purohit P, de Graaf RA, Esterlis I, Juchem C, Pittman BP, Krystal JH, Rothman DL, Sanacora G, Mason GF. The effects of ketamine on prefrontal glutamate neurotransmission in healthy and depressed subjects. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 29977074 DOI: 10.1038/S41386-018-0136-3 |
0.566 |
|
| 2018 |
Chekroud AM, Foster D, Zheutlin AB, Gerhard DM, Roy B, Koutsouleris N, Chandra A, Esposti MD, Subramanyan G, Gueorguieva R, Paulus M, Krystal JH. Predicting Barriers to Treatment for Depression in a U.S. National Sample: A Cross-Sectional, Proof-of-Concept Study. Psychiatric Services (Washington, D.C.). appips201800094. PMID 29962307 DOI: 10.1176/Appi.Ps.201800094 |
0.672 |
|
| 2018 |
Abdallah CG, Sanacora G, Duman RS, Krystal JH. The neurobiology of depression, ketamine and rapid-acting antidepressants: Is it glutamate inhibition or activation? Pharmacology & Therapeutics. PMID 29803629 DOI: 10.1016/J.Pharmthera.2018.05.010 |
0.565 |
|
| 2018 |
Akiki TJ, Averill CL, Wrocklage KM, Scott JC, Averill LA, Schweinsburg B, Alexander-Bloch A, Martini B, Southwick SM, Krystal JH, Abdallah CG. Default mode network abnormalities in posttraumatic stress disorder: A novel network-restricted topology approach. Neuroimage. PMID 29730491 DOI: 10.1016/J.Neuroimage.2018.05.005 |
0.646 |
|
| 2018 |
D'Souza DC, Carson RE, Driesen N, Johannesen J, Ranganathan M, Krystal JH. Dose-Related Target Occupancy and Effects on Circuitry, Behavior, and Neuroplasticity of the Glycine Transporter-1 Inhibitor PF-03463275 in Healthy and Schizophrenia Subjects. Biological Psychiatry. PMID 29499855 DOI: 10.1016/J.Biopsych.2017.12.019 |
0.3 |
|
| 2018 |
Preller KH, Burt JB, Ji JL, Schleifer CH, Adkinson BD, Stämpfli P, Seifritz E, Repovs G, Krystal JH, Murray JD, Vollenweider FX, Anticevic A. Author response: Changes in global and thalamic brain connectivity in LSD-induced altered states of consciousness are attributable to the 5-HT2A receptor Elife. DOI: 10.7554/Elife.35082.028 |
0.533 |
|
| 2018 |
Cho Y, Schleifer C, Moujaes F, Starc M, Ji JL, Santamauro N, Adkinson B, Lituchy M, Krystal J, Murray J, Repovs G, Anticevic A. S232. Effects of Incentive Presentation on Spatial Working Memory Performance Biological Psychiatry. 83: S438. DOI: 10.1016/J.Biopsych.2018.02.1124 |
0.5 |
|
| 2017 |
Kelmendi B, Adams TG, Southwick S, Abdallah CG, Krystal JH. Posttraumatic Stress Disorder: an integrated overview and neurobiological rationale for pharmacology. Clinical Psychology : a Publication of the Division of Clinical Psychology of the American Psychological Association. 24: 281-297. PMID 31404451 DOI: 10.1111/Cpsp.12202 |
0.322 |
|
| 2017 |
Averill CL, Satodiya RM, Scott JC, Wrocklage KM, Schweinsburg B, Averill LA, Akiki TJ, Amoroso T, Southwick SM, Krystal JH, Abdallah CG. Posttraumatic Stress Disorder and Depression Symptom Severities Are Differentially Associated With Hippocampal Subfield Volume Loss in Combat Veterans. Chronic Stress (Thousand Oaks, Calif.). 1. PMID 29520395 |
0.625 |
|
| 2017 |
Logue MW, van Rooij SJH, Dennis EL, Davis SL, Hayes JP, Stevens JS, Densmore M, Haswell CC, Ipser J, Koch SBJ, Korgaonkar M, Lebois LAM, Peverill M, Baker JT, Boedhoe PSW, ... ... Krystal JH, et al. Smaller Hippocampal Volume in Posttraumatic Stress Disorder: A Multisite ENIGMA-PGC Study: Subcortical Volumetry Results From Posttraumatic Stress Disorder Consortia. Biological Psychiatry. PMID 29217296 DOI: 10.1016/J.Biopsych.2017.09.006 |
0.306 |
|
| 2017 |
Javitt DC, Carter CS, Krystal JH, Kantrowitz JT, Girgis RR, Kegeles LS, Ragland JD, Maddock RJ, Lesh TA, Tanase C, Corlett PR, Rothman DL, Mason G, Qiu M, Robinson J, et al. Utility of Imaging-Based Biomarkers for Glutamate-Targeted Drug Development in Psychotic Disorders: A Randomized Clinical Trial. Jama Psychiatry. PMID 29167877 DOI: 10.1001/Jamapsychiatry.2017.3572 |
0.308 |
|
| 2017 |
Esterlis I, Holmes SE, Sharma P, Krystal JH, DeLorenzo C. Metabotropic Glutamatergic Receptor 5 and Stress Disorders: Knowledge Gained From Receptor Imaging Studies. Biological Psychiatry. PMID 29100629 DOI: 10.1016/J.Biopsych.2017.08.025 |
0.362 |
|
| 2017 |
Abdallah CG, Averill CL, Salas R, Averill LA, Baldwin PR, Krystal JH, Mathew SJ, Mathalon DH. Prefrontal Connectivity and Glutamate Transmission: Relevance to Depression Pathophysiology and Ketamine Treatment. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. 2: 566-574. PMID 29034354 DOI: 10.1016/J.Bpsc.2017.04.006 |
0.336 |
|
| 2017 |
Taylor JJ, Krystal JH, D'Souza DC, Gerrard JL, Corlett PR. Targeted neural network interventions for auditory hallucinations: Can TMS inform DBS? Schizophrenia Research. PMID 28969932 DOI: 10.1016/J.Schres.2017.09.020 |
0.305 |
|
| 2017 |
Krystal JH, Abdallah CG, Averill LA, Kelmendi B, Harpaz-Rotem I, Sanacora G, Southwick SM, Duman RS. Synaptic Loss and the Pathophysiology of PTSD: Implications for Ketamine as a Prototype Novel Therapeutic. Current Psychiatry Reports. 19: 74. PMID 28844076 DOI: 10.1007/S11920-017-0829-Z |
0.548 |
|
| 2017 |
Akiki TJ, Averill CL, Wrocklage KM, Schweinsburg B, Scott JC, Martini B, Averill LA, Southwick SM, Krystal JH, Abdallah CG. The Association of PTSD Symptom Severity with Localized Hippocampus and Amygdala Abnormalities. Chronic Stress (Thousand Oaks, Calif.). 1. PMID 28825050 |
0.611 |
|
| 2017 |
Andersen AM, Pietrzak RH, Kranzler HR, Ma L, Zhou H, Liu X, Kramer J, Kuperman S, Edenberg HJ, Nurnberger JI, Rice JP, Tischfield JA, Goate A, Foroud TM, Meyers JL, ... ... Krystal JH, et al. Polygenic Scores for Major Depressive Disorder and Risk of Alcohol Dependence. Jama Psychiatry. PMID 28813562 DOI: 10.1001/Jamapsychiatry.2017.2269 |
0.314 |
|
| 2017 |
Holmes SE, Girgenti MJ, Davis MT, Pietrzak RH, DellaGioia N, Nabulsi N, Matuskey D, Southwick S, Duman RS, Carson RE, Krystal JH, Esterlis I. Altered metabotropic glutamate receptor 5 markers in PTSD: In vivo and postmortem evidence. Proceedings of the National Academy of Sciences of the United States of America. PMID 28716937 DOI: 10.1073/Pnas.1701749114 |
0.332 |
|
| 2017 |
Wisco BE, Marx BP, Miller MW, Wolf EJ, Krystal JH, Southwick SM, Pietrzak RH. A comparison of ICD-11 and DSM criteria for posttraumatic stress disorder in two national samples of U.S. military veterans. Journal of Affective Disorders. 223: 17-19. PMID 28715723 DOI: 10.1016/J.Jad.2017.07.006 |
0.311 |
|
| 2017 |
Krystal JH, Anticevic A, Yang GJ, Dragoi G, Driesen NR, Wang XJ, Murray JD. Impaired Tuning of Neural Ensembles and the Pathophysiology of Schizophrenia: A Translational and Computational Neuroscience Perspective. Biological Psychiatry. 81: 874-885. PMID 28434616 DOI: 10.1016/J.Biopsych.2017.01.004 |
0.69 |
|
| 2017 |
Foss-Feig JH, Adkinson BD, Ji JL, Yang G, Srihari VH, McPartland JC, Krystal JH, Murray JD, Anticevic A. Searching for Cross-Diagnostic Convergence: Neural Mechanisms Governing Excitation and Inhibition Balance in Schizophrenia and Autism Spectrum Disorders. Biological Psychiatry. 81: 848-861. PMID 28434615 DOI: 10.1016/J.Biopsych.2017.03.005 |
0.691 |
|
| 2017 |
Esterlis I, DellaGioia N, Pietrzak RH, Matuskey D, Nabulsi N, Abdallah CG, Yang J, Pittenger C, Sanacora G, Krystal JH, Parsey RV, Carson RE, DeLorenzo C. Ketamine-induced reduction in mGluR5 availability is associated with an antidepressant response: an [(11)C]ABP688 and PET imaging study in depression. Molecular Psychiatry. PMID 28397841 DOI: 10.1038/Mp.2017.58 |
0.565 |
|
| 2017 |
Chekroud AM, Loho H, Krystal JH. Mental illness and mental health. The Lancet. Psychiatry. 4: 276-277. PMID 28347431 DOI: 10.1016/S2215-0366(17)30088-3 |
0.641 |
|
| 2017 |
Krystal JH, Murray JD, Chekroud AM, Corlett PR, Yang G, Wang XJ, Anticevic A. Computational Psychiatry and the Challenge of Schizophrenia. Schizophrenia Bulletin. PMID 28338845 DOI: 10.1093/Schbul/Sbx025 |
0.783 |
|
| 2017 |
Wrocklage KM, Averill LA, Cobb Scott J, Averill CL, Schweinsburg B, Trejo M, Roy A, Weisser V, Kelly C, Martini B, Harpaz-Rotem I, Southwick SM, Krystal JH, Abdallah CG. Cortical thickness reduction in combat exposed U.S. veterans with and without PTSD. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 28279623 DOI: 10.1016/J.Euroneuro.2017.02.010 |
0.302 |
|
| 2017 |
Abdallah CG, Wrocklage KM, Averill CL, Akiki T, Schweinsburg B, Roy A, Martini B, Southwick SM, Krystal JH, Scott JC. Anterior hippocampal dysconnectivity in posttraumatic stress disorder: a dimensional and multimodal approach. Translational Psychiatry. 7: e1045. PMID 28244983 DOI: 10.1038/Tp.2017.12 |
0.35 |
|
| 2017 |
Chekroud AM, Gueorguieva R, Krumholz HM, Trivedi MH, Krystal JH, McCarthy G. Reevaluating the Efficacy and Predictability of Antidepressant Treatments: A Symptom Clustering Approach. Jama Psychiatry. PMID 28241180 DOI: 10.1001/Jamapsychiatry.2017.0025 |
0.678 |
|
| 2017 |
Gueorguieva R, Chekroud AM, Krystal JH. Trajectories of relapse in randomised, placebo-controlled trials of treatment discontinuation in major depressive disorder: an individual patient-level data meta-analysis. The Lancet. Psychiatry. PMID 28189575 DOI: 10.1016/S2215-0366(17)30038-X |
0.687 |
|
| 2017 |
Anticevic A, Schleifer C, Srihari V, Krystal J, Murray J, Repovs G, Xu G, Ji L, Cho Y, Santamauro N, Foss-Feig J, Yang G, Morgan P, Savic A. 423. NMDAR Antagonism via Ketamine Differentially Modulates Thalamic versus Hippocampal Functional Connectivity Biological Psychiatry. 81: S172-S173. DOI: 10.1016/J.Biopsych.2017.02.907 |
0.652 |
|
| 2017 |
Cho Y, Schleifer C, Starc M, Lisa Ji J, Santamauro N, Adkinson B, Lituchy M, Krystal J, Murray J, Repovs G, Anticevic A. 961. Incentives to Perform: The Effects of Reward on Working Memory Biological Psychiatry. 81: S389. DOI: 10.1016/J.Biopsych.2017.02.687 |
0.502 |
|
| 2017 |
Preller K, Schleifer C, Stämpfli P, Krystal J, Vollenweider F, Anticevic A. 951. Changes in Resting-State Global Brain Connectivity in LSD-Induced Altered States of Consciousness are Attributable to the 5-HT2A Receptor Biological Psychiatry. 81: S385. DOI: 10.1016/J.Biopsych.2017.02.677 |
0.526 |
|
| 2016 |
Krystal JH, Abi-Dargham A, Barch DM, Bullmore ET, Carter CS, Geschwind DH, Harrison PJ, Nestler EJ, Stein MB. Biological Psychiatry and Biological Psychiatry: Cognitive Neuroscience and Neuroimaging Adopt Neuroscience-Based Nomenclature. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. 1: 300-301. PMID 29560862 DOI: 10.1016/J.Bpsc.2016.03.007 |
0.388 |
|
| 2016 |
Steine IM, Zayats T, Stansberg C, Pallesen S, Mrdalj J, Håvik B, Soulé J, Haavik J, Milde AM, Skrede S, Murison R, Krystal J, Grønli J. Implication of NOTCH1 gene in susceptibility to anxiety and depression among sexual abuse victims. Translational Psychiatry. 6: e977. PMID 27959334 DOI: 10.1038/Tp.2016.248 |
0.308 |
|
| 2016 |
Averill LA, Purohit P, Averill CL, Boesl MA, Krystal JH, Abdallah CG. Glutamate Dysregulation and Glutamatergic Therapeutics for PTSD: Evidence from Human Studies. Neuroscience Letters. PMID 27916636 DOI: 10.1016/J.Neulet.2016.11.064 |
0.339 |
|
| 2016 |
Kelmendi B, Adams TG, Yarnell S, Southwick S, Abdallah CG, Krystal JH. PTSD: from neurobiology to pharmacological treatments. European Journal of Psychotraumatology. 7: 31858. PMID 27837583 DOI: 10.3402/Ejpt.V7.31858 |
0.32 |
|
| 2016 |
Khlestova E, Johnson JW, Krystal JH, Lisman J. The Role of GluN2C-Containing NMDA Receptors in Ketamine's Psychotogenic Action and in Schizophrenia Models. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 36: 11151-11157. PMID 27807157 DOI: 10.1523/Jneurosci.1203-16.2016 |
0.34 |
|
| 2016 |
Starc M, Murray JD, Santamauro N, Savic A, Diehl C, Cho YT, Srihari V, Morgan PT, Krystal JH, Wang XJ, Repovs G, Anticevic A. Schizophrenia is associated with a pattern of spatial working memory deficits consistent with cortical disinhibition. Schizophrenia Research. PMID 27745755 DOI: 10.1016/J.Schres.2016.10.011 |
0.576 |
|
| 2016 |
Yang GJ, Murray JD, Glasser M, Pearlson GD, Krystal JH, Schleifer C, Repovs G, Anticevic A. Altered Global Signal Topography in Schizophrenia. Cerebral Cortex (New York, N.Y. : 1991). PMID 27702810 DOI: 10.1093/Cercor/Bhw297 |
0.68 |
|
| 2016 |
Kort NS, Ford JM, Roach BJ, Gunduz-Bruce H, Krystal JH, Jaeger J, Reinhart RM, Mathalon DH. Role of N-Methyl D-Aspartate Receptors in Action-Based Predictive Coding Deficits in Schizophrenia. Biological Psychiatry. PMID 27647218 DOI: 10.1016/J.Biopsych.2016.06.019 |
0.323 |
|
| 2016 |
Wisco BE, Marx BP, Miller MW, Wolf EJ, Mota NP, Krystal JH, Southwick SM, Pietrzak RH. Probable Posttraumatic Stress Disorder in the US Veteran Population According to DSM-5: Results From the National Health and Resilience in Veterans Study. The Journal of Clinical Psychiatry. PMID 27631148 DOI: 10.4088/Jcp.15M10188 |
0.307 |
|
| 2016 |
Gerin MI, Fichtenholtz H, Roy A, Walsh CJ, Krystal JH, Southwick S, Hampson M. Real-Time fMRI Neurofeedback with War Veterans with Chronic PTSD: A Feasibility Study. Frontiers in Psychiatry. 7: 111. PMID 27445868 DOI: 10.3389/Fpsyt.2016.00111 |
0.301 |
|
| 2016 |
Heinz A, Voss M, Lawrie SM, Mishara A, Bauer M, Gallinat J, Juckel G, Lang U, Rapp M, Falkai P, Strik W, Krystal J, Abi-Dargham A, Galderisi S. Shall we really say goodbye to first rank symptoms? European Psychiatry : the Journal of the Association of European Psychiatrists. 37: 8-13. PMID 27429167 DOI: 10.1016/J.Eurpsy.2016.04.010 |
0.315 |
|
| 2016 |
Scott JC, Woods SP, Wrocklage KM, Schweinsburg BC, Southwick SM, Krystal JH. Prospective Memory in Posttraumatic Stress Disorder. Journal of the International Neuropsychological Society : Jins. 1-11. PMID 27353125 DOI: 10.1017/S1355617716000564 |
0.689 |
|
| 2016 |
Krystal JH, Abi-Dargham A, Akbarian S, Arnsten AF, Barch DM, Bearden CE, Braff DL, Brown ES, Bullmore ET, Carlezon WA, Carter CS, Cook EH, Daskalakis ZJ, DiLeone RJ, Duman RS, et al. Constance E. Lieber, Theodore R. Stanley, and the Enduring Impact of Philanthropy on Psychiatry Research. Biological Psychiatry. 80: 84-6. PMID 27346079 DOI: 10.1016/J.Biopsych.2016.05.004 |
0.617 |
|
| 2016 |
Krystal JH, Abi-Dargham A, Barch DM, Bullmore ET, Carter CS, Geschwind DH, Harrison PJ, Nestler EJ, Stein MB. Biological Psychiatry and Biological Psychiatry: Cognitive Neuroscience and Neuroimaging Adopt Neuroscience-Based Nomenclature. Biological Psychiatry. 80: 2-3. PMID 27312230 DOI: 10.1016/J.Biopsych.2016.03.2103 |
0.403 |
|
| 2016 |
Mota NP, Tsai J, Sareen J, Marx BP, Wisco BE, Harpaz-Rotem I, Southwick SM, Krystal JH, Pietrzak RH. High burden of subthreshold DSM-5 post-traumatic stress disorder in U.S. military veterans. World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 15: 185-186. PMID 27265715 DOI: 10.1002/Wps.20313 |
0.322 |
|
| 2016 |
Murrough JW, Abdallah CG, Anticevic A, Collins KA, Geha P, Averill LA, Schwartz J, DeWilde KE, Averill C, Jia-Wei Yang G, Wong E, Tang CY, Krystal JH, Iosifescu DV, Charney DS. Reduced global functional connectivity of the medial prefrontal cortex in major depressive disorder. Human Brain Mapping. PMID 27144347 DOI: 10.1002/Hbm.23235 |
0.645 |
|
| 2016 |
Abdallah CG, Adams TG, Kelmendi B, Esterlis I, Sanacora G, Krystal JH. KETAMINE'S MECHANISM OF ACTION: A PATH TO RAPID-ACTING ANTIDEPRESSANTS. Depression and Anxiety. PMID 27062302 DOI: 10.1002/Da.22501 |
0.539 |
|
| 2016 |
Rich AM, Cho YT, Tang Y, Savic A, Krystal JH, Wang F, Xu K, Anticevic A. Amygdala volume is reduced in early course schizophrenia. Psychiatry Research. 250: 50-60. PMID 27035063 DOI: 10.1016/J.Pscychresns.2016.02.006 |
0.567 |
|
| 2016 |
Duman RS, Aghajanian GK, Sanacora G, Krystal JH. Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants. Nature Medicine. 22: 238-49. PMID 26937618 DOI: 10.1038/Nm.4050 |
0.572 |
|
| 2016 |
Wrocklage KM, Schweinsburg BC, Krystal JH, Trejo M, Roy A, Weisser V, Moore TM, Southwick SM, Scott JC. Neuropsychological Functioning in Veterans with Posttraumatic Stress Disorder: Associations with Performance Validity, Comorbidities, and Functional Outcomes. Journal of the International Neuropsychological Society : Jins. 1-13. PMID 26892753 DOI: 10.1017/S1355617716000059 |
0.65 |
|
| 2016 |
Southwick SM, Sippel L, Krystal J, Charney D, Mayes L, Pietrzak R. Why are some individuals more resilient than others: the role of social support. World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 15: 77-9. PMID 26833614 DOI: 10.1002/Wps.20282 |
0.379 |
|
| 2016 |
Chekroud AM, Zotti RJ, Shehzad Z, Gueorguieva R, Johnson MK, Trivedi MH, Cannon TD, Krystal JH, Corlett PR. Cross-trial prediction of treatment outcome in depression: a machine learning approach. The Lancet. Psychiatry. PMID 26803397 DOI: 10.1016/S2215-0366(15)00471-X |
0.677 |
|
| 2016 |
Chekroud A, Zotti R, Shehzad Z, Gueorguieva R, Johnson M, Trivedi M, Cannon T, Krystal J, Corlett P. Cross-trial prediction of treatment outcomes in depression F1000research. 5. DOI: 10.7490/F1000Research.1111949.1 |
0.662 |
|
| 2016 |
Krystal JH, Sanacora G, Abdallah C, Duman R. Speaker 4: John Krystal, USA. The International Journal of Neuropsychopharmacology. 19: 19-19. DOI: 10.1093/Ijnp/Pyw042.052 |
0.472 |
|
| 2016 |
Krystal JH, Anticevic A, Yang G, Driesen N, Cortes-Briones J, Stone JM, Wang X, Murray JD. Speaker 3: John Krystal, USA The International Journal of Neuropsychopharmacology. 19: 5-5. DOI: 10.1093/Ijnp/Pyw042.007 |
0.616 |
|
| 2015 |
Southwick SM, Pietrzak RH, Charney DS, Krystal JH. Resilience: The role of accurate appraisal, thresholds, and socioenvironmental factors. The Behavioral and Brain Sciences. 38: e122. PMID 26786005 DOI: 10.1017/S0140525X14001708 |
0.411 |
|
| 2015 |
Yang GJ, Murray JD, Wang XJ, Glahn DC, Pearlson GD, Repovs G, Krystal JH, Anticevic A. Functional hierarchy underlies preferential connectivity disturbances in schizophrenia. Proceedings of the National Academy of Sciences of the United States of America. PMID 26699491 DOI: 10.1073/Pnas.1508436113 |
0.692 |
|
| 2015 |
Krystal JH, Anticevic A. Toward Illness Phase-Specific Pharmacotherapy for Schizophrenia. Biological Psychiatry. 78: 738-40. PMID 26542740 DOI: 10.1016/J.Biopsych.2015.08.017 |
0.544 |
|
| 2015 |
Licznerski P, Duric V, Banasr M, Alavian KN, Ota KT, Kang HJ, Jonas EA, Ursano R, Krystal JH, Duman RS. Decreased SGK1 Expression and Function Contributes to Behavioral Deficits Induced by Traumatic Stress. Plos Biology. 13: e1002282. PMID 26506154 DOI: 10.1371/Journal.Pbio.1002282 |
0.327 |
|
| 2015 |
Corbin WR, Papova A, Morean ME, O'Malley SS, Krishnan-Sarin S, Abi-Dargham A, Anticevic A, Pearlson G, Petrakis I, Pittman BP, Krystal JH. Integrating Acquired Preparedness and Dual Process Models of Risk for Heavy Drinking and Related Problems. Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors. PMID 26348221 DOI: 10.1037/Adb0000093 |
0.527 |
|
| 2015 |
Stone J, Kotoula V, Dietrich C, De Simoni S, Krystal JH, Mehta MA. Perceptual distortions and delusional thinking following ketamine administration are related to increased pharmacological MRI signal changes in the parietal lobe. Journal of Psychopharmacology (Oxford, England). 29: 1025-8. PMID 26152321 DOI: 10.1177/0269881115592337 |
0.321 |
|
| 2015 |
Chekroud AM, Krystal JH. Personalised pharmacotherapy: an interim solution for antidepressant treatment? Bmj (Clinical Research Ed.). 350: h2502. PMID 25976040 DOI: 10.1136/Bmj.H2502 |
0.68 |
|
| 2015 |
Ahn KH, Sewell A, Elander J, Pittman B, Ranganathan M, Gunduz-Bruce H, Krystal J, D'Souza DC. Role of GABA Deficit in Sensitivity to the Psychotomimetic Effects of Amphetamine. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 25953357 DOI: 10.1038/Npp.2015.132 |
0.334 |
|
| 2015 |
Abdallah CG, Averill LA, Krystal JH. Ketamine as a promising prototype for a new generation of rapid-acting antidepressants. Annals of the New York Academy of Sciences. 1344: 66-77. PMID 25727103 DOI: 10.1111/Nyas.12718 |
0.344 |
|
| 2015 |
Krystal JH. Deconstructing N-methyl-d-aspartate glutamate receptor contributions to cortical circuit functions to construct better hypotheses about the pathophysiology of schizophrenia. Biological Psychiatry. 77: 508-10. PMID 25687430 DOI: 10.1016/J.Biopsych.2014.10.010 |
0.36 |
|
| 2015 |
Anticevic A, Hu X, Xiao Y, Hu J, Li F, Bi F, Cole MW, Savic A, Yang GJ, Repovs G, Murray JD, Wang XJ, Huang X, Lui S, Krystal JH, et al. Early-course unmedicated schizophrenia patients exhibit elevated prefrontal connectivity associated with longitudinal change. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 35: 267-86. PMID 25568120 DOI: 10.1523/Jneurosci.2310-14.2015 |
0.704 |
|
| 2015 |
Tsai J, Harpaz-Rotem I, Armour C, Southwick SM, Krystal JH, Pietrzak RH. Dimensional structure of DSM-5 posttraumatic stress disorder symptoms: results from the National Health and Resilience in Veterans Study. The Journal of Clinical Psychiatry. 76: 546-53. PMID 25562376 DOI: 10.4088/Jcp.14M09091 |
0.312 |
|
| 2015 |
Xu K, Krystal JH, Ning Y, Chen da C, He H, Wang D, Ke X, Zhang X, Ding Y, Liu Y, Gueorguieva R, Wang Z, Limoncelli D, Pietrzak RH, Petrakis IL, et al. Preliminary analysis of positive and negative syndrome scale in ketamine-associated psychosis in comparison with schizophrenia. Journal of Psychiatric Research. 61: 64-72. PMID 25560772 DOI: 10.1016/J.Jpsychires.2014.12.012 |
0.321 |
|
| 2015 |
Scott JC, Matt GE, Wrocklage KM, Crnich C, Jordan J, Southwick SM, Krystal JH, Schweinsburg BC. A quantitative meta-analysis of neurocognitive functioning in posttraumatic stress disorder. Psychological Bulletin. 141: 105-40. PMID 25365762 DOI: 10.1037/A0038039 |
0.645 |
|
| 2015 |
Abdallah CG, Sanacora G, Duman RS, Krystal JH. Ketamine and rapid-acting antidepressants: a window into a new neurobiology for mood disorder therapeutics. Annual Review of Medicine. 66: 509-23. PMID 25341010 DOI: 10.1146/Annurev-Med-053013-062946 |
0.559 |
|
| 2015 |
Anticevic A, Corlett PR, Cole MW, Savic A, Gancsos M, Tang Y, Repovs G, Murray JD, Driesen NR, Morgan PT, Xu K, Wang F, Krystal JH. N-methyl-D-aspartate receptor antagonist effects on prefrontal cortical connectivity better model early than chronic schizophrenia. Biological Psychiatry. 77: 569-80. PMID 25281999 DOI: 10.1016/J.Biopsych.2014.07.022 |
0.585 |
|
| 2015 |
DeLorenzo C, DellaGioia N, Bloch M, Sanacora G, Nabulsi N, Abdallah C, Yang J, Wen R, Mann JJ, Krystal JH, Parsey RV, Carson RE, Esterlis I. In vivo ketamine-induced changes in [¹¹C]ABP688 binding to metabotropic glutamate receptor subtype 5. Biological Psychiatry. 77: 266-75. PMID 25156701 DOI: 10.1016/J.Biopsych.2014.06.024 |
0.528 |
|
| 2015 |
Anticevic A, Savic A, Repovs G, Yang G, McKay DR, Sprooten E, Knowles EE, Krystal JH, Pearlson GD, Glahn DC. Ventral anterior cingulate connectivity distinguished nonpsychotic bipolar illness from psychotic bipolar disorder and schizophrenia. Schizophrenia Bulletin. 41: 133-43. PMID 24782562 DOI: 10.1093/Schbul/Sbu051 |
0.708 |
|
| 2014 |
Pietrzak RH, Rosenheck RA, Cramer JA, Vessichio JC, Tsai J, Southwick SM, Krystal JH. Elucidating the transdiagnostic dimensional structure of trauma-related psychopathology: Findings from VA cooperative study 504 - risperidone treatment for military service related chronic post traumatic stress disorder. Journal of Affective Disorders. 172: 331-336. PMID 25451434 DOI: 10.1016/J.Jad.2014.10.025 |
0.326 |
|
| 2014 |
Abdallah CG, Jiang L, De Feyter HM, Fasula M, Krystal JH, Rothman DL, Mason GF, Sanacora G. Glutamate metabolism in major depressive disorder. The American Journal of Psychiatry. 171: 1320-7. PMID 25073688 DOI: 10.1176/Appi.Ajp.2014.14010067 |
0.566 |
|
| 2014 |
Morean ME, DeMartini KS, Leeman RF, Pearlson GD, Anticevic A, Krishnan-Sarin S, Krystal JH, O'Malley SS. Psychometrically improved, abbreviated versions of three classic measures of impulsivity and self-control. Psychological Assessment. 26: 1003-20. PMID 24885848 DOI: 10.1037/Pas0000003 |
0.513 |
|
| 2014 |
Yang GJ, Murray JD, Repovs G, Cole MW, Savic A, Glasser MF, Pittenger C, Krystal JH, Wang XJ, Pearlson GD, Glahn DC, Anticevic A. Altered global brain signal in schizophrenia. Proceedings of the National Academy of Sciences of the United States of America. 111: 7438-43. PMID 24799682 DOI: 10.1073/Pnas.1405289111 |
0.689 |
|
| 2014 |
Krystal JH, State MW. Psychiatric disorders: diagnosis to therapy. Cell. 157: 201-14. PMID 24679536 DOI: 10.1016/J.Cell.2014.02.042 |
0.3 |
|
| 2014 |
Stefanovics EA, Krystal JH, Rosenheck RA. Symptom structure and severity: a comparison of responses to the positive and negative syndrome scale (PANSS) between patients with PTSD or schizophrenia. Comprehensive Psychiatry. 55: 887-95. PMID 24602497 DOI: 10.1016/J.Comppsych.2014.01.014 |
0.334 |
|
| 2014 |
Leatherman SM, Liang MH, Krystal JH, Lew RA, Valley D, Thwin SS, Rosenheck RA. Differences in treatment effect among clinical subgroups in a randomized clinical trial of long-acting injectable risperidone and oral antipsychotics in unstable chronic schizophrenia. The Journal of Nervous and Mental Disease. 202: 13-7. PMID 24375206 DOI: 10.1097/Nmd.0000000000000069 |
0.33 |
|
| 2014 |
Anticevic A, Tang Y, Cho YT, Repovs G, Cole MW, Savic A, Wang F, Krystal JH, Xu K. Amygdala connectivity differs among chronic, early course, and individuals at risk for developing schizophrenia. Schizophrenia Bulletin. 40: 1105-16. PMID 24366718 DOI: 10.1093/Schbul/Sbt165 |
0.583 |
|
| 2014 |
Boggs DL, Carlson J, Cortes-Briones J, Krystal JH, D'Souza DC. Going up in smoke? A review of nAChRs-based treatment strategies for improving cognition in schizophrenia. Current Pharmaceutical Design. 20: 5077-92. PMID 24345265 DOI: 10.2174/1381612819666131216121019 |
0.311 |
|
| 2014 |
Anticevic A, Hu S, Zhang S, Savic A, Billingslea E, Wasylink S, Repovs G, Cole MW, Bednarski S, Krystal JH, Bloch MH, Li CS, Pittenger C. Global resting-state functional magnetic resonance imaging analysis identifies frontal cortex, striatal, and cerebellar dysconnectivity in obsessive-compulsive disorder. Biological Psychiatry. 75: 595-605. PMID 24314349 DOI: 10.1016/J.Biopsych.2013.10.021 |
0.564 |
|
| 2014 |
Anticevic A, Cole MW, Repovs G, Murray JD, Brumbaugh MS, Winkler AM, Savic A, Krystal JH, Pearlson GD, Glahn DC. Characterizing thalamo-cortical disturbances in schizophrenia and bipolar illness. Cerebral Cortex (New York, N.Y. : 1991). 24: 3116-30. PMID 23825317 DOI: 10.1093/Cercor/Bht165 |
0.586 |
|
| 2014 |
Murray JD, Anticevic A, Gancsos M, Ichinose M, Corlett PR, Krystal JH, Wang XJ. Linking microcircuit dysfunction to cognitive impairment: effects of disinhibition associated with schizophrenia in a cortical working memory model. Cerebral Cortex (New York, N.Y. : 1991). 24: 859-72. PMID 23203979 DOI: 10.1093/Cercor/Bhs370 |
0.582 |
|
| 2014 |
Anticevic A, Murray J, Repovs G, Starc M, Santamauro N, Savic A, Morgan P, Wang X, Krystal J. 5:45 PM INTEGRATING PHARMACOLOGY AND COMPUTATION: TOWARDS UNDERSTANDING MECHANISMS OF COGNITIVE AND CONNECTIVITY DEFICITS IN SCHIZOPHRENIA Schizophrenia Research. 153: S52-S53. DOI: 10.1016/S0920-9964(14)70172-0 |
0.548 |
|
| 2013 |
Anticevic A, Cole MW, Repovs G, Savic A, Driesen NR, Yang G, Cho YT, Murray JD, Glahn DC, Wang XJ, Krystal JH. Connectivity, pharmacology, and computation: toward a mechanistic understanding of neural system dysfunction in schizophrenia. Frontiers in Psychiatry. 4: 169. PMID 24399974 DOI: 10.3389/Fpsyt.2013.00169 |
0.702 |
|
| 2013 |
Driesen NR, McCarthy G, Bhagwagar Z, Bloch MH, Calhoun VD, D'Souza DC, Gueorguieva R, He G, Leung HC, Ramani R, Anticevic A, Suckow RF, Morgan PT, Krystal JH. The impact of NMDA receptor blockade on human working memory-related prefrontal function and connectivity. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 38: 2613-22. PMID 23856634 DOI: 10.1038/Npp.2013.170 |
0.578 |
|
| 2013 |
Krystal JH, Sanacora G, Duman RS. Rapid-acting glutamatergic antidepressants: the path to ketamine and beyond. Biological Psychiatry. 73: 1133-41. PMID 23726151 DOI: 10.1016/J.Biopsych.2013.03.026 |
0.56 |
|
| 2013 |
Zuo L, Wang K, Zhang XY, Pan X, Wang G, Tan Y, Zhong C, Krystal JH, State M, Zhang H, Luo X. Association between common alcohol dehydrogenase gene (ADH) variants and schizophrenia and autism. Human Genetics. 132: 735-43. PMID 23468174 DOI: 10.1007/S00439-013-1277-4 |
0.313 |
|
| 2013 |
Narayanan B, Stevens MC, Jiantonio RE, Krystal JH, Pearlson GD. Effects of memantine on event-related potential, oscillations, and complexity in individuals with and without family histories of alcoholism. Journal of Studies On Alcohol and Drugs. 74: 245-57. PMID 23384372 DOI: 10.15288/Jsad.2013.74.245 |
0.307 |
|
| 2013 |
Driesen NR, McCarthy G, Bhagwagar Z, Bloch M, Calhoun V, D'Souza DC, Gueorguieva R, He G, Ramachandran R, Suckow RF, Anticevic A, Morgan PT, Krystal JH. Relationship of resting brain hyperconnectivity and schizophrenia-like symptoms produced by the NMDA receptor antagonist ketamine in humans. Molecular Psychiatry. 18: 1199-204. PMID 23337947 DOI: 10.1038/Mp.2012.194 |
0.593 |
|
| 2013 |
Woods SW, Walsh BC, Hawkins KA, Miller TJ, Saksa JR, D'Souza DC, Pearlson GD, Javitt DC, McGlashan TH, Krystal JH. Glycine treatment of the risk syndrome for psychosis: report of two pilot studies. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 23: 931-40. PMID 23089076 DOI: 10.1016/J.Euroneuro.2012.09.008 |
0.317 |
|
| 2013 |
Anticevic A, Brumbaugh MS, Winkler AM, Lombardo LE, Barrett J, Corlett PR, Kober H, Gruber J, Repovs G, Cole MW, Krystal JH, Pearlson GD, Glahn DC. Global prefrontal and fronto-amygdala dysconnectivity in bipolar I disorder with psychosis history. Biological Psychiatry. 73: 565-73. PMID 22980587 DOI: 10.1016/J.Biopsych.2012.07.031 |
0.604 |
|
| 2012 |
Anticevic A, Cole MW, Murray JD, Corlett PR, Wang XJ, Krystal JH. The role of default network deactivation in cognition and disease. Trends in Cognitive Sciences. 16: 584-92. PMID 23142417 DOI: 10.1016/J.Tics.2012.10.008 |
0.541 |
|
| 2012 |
Anticevic A, Gancsos M, Murray JD, Repovs G, Driesen NR, Ennis DJ, Niciu MJ, Morgan PT, Surti TS, Bloch MH, Ramani R, Smith MA, Wang XJ, Krystal JH, Corlett PR. NMDA receptor function in large-scale anticorrelated neural systems with implications for cognition and schizophrenia. Proceedings of the National Academy of Sciences of the United States of America. 109: 16720-5. PMID 23012427 DOI: 10.1073/Pnas.1208494109 |
0.584 |
|
| 2012 |
Moghaddam B, Krystal JH. Capturing the angel in "angel dust": twenty years of translational neuroscience studies of NMDA receptor antagonists in animals and humans. Schizophrenia Bulletin. 38: 942-9. PMID 22899397 DOI: 10.1093/Schbul/Sbs075 |
0.345 |
|
| 2012 |
Anticevic A, Repovs G, Krystal JH, Barch DM. A broken filter: prefrontal functional connectivity abnormalities in schizophrenia during working memory interference. Schizophrenia Research. 141: 8-14. PMID 22863548 DOI: 10.1016/J.Schres.2012.07.007 |
0.576 |
|
| 2012 |
Bloch MH, Wasylink S, Landeros-Weisenberger A, Panza KE, Billingslea E, Leckman JF, Krystal JH, Bhagwagar Z, Sanacora G, Pittenger C. Effects of ketamine in treatment-refractory obsessive-compulsive disorder. Biological Psychiatry. 72: 964-70. PMID 22784486 DOI: 10.1016/J.Biopsych.2012.05.028 |
0.578 |
|
| 2012 |
Nestler EJ, Krystal JH. Planning the new national institute on substance use and addiction disorders. Biological Psychiatry. 72: 166-7. PMID 22683089 DOI: 10.1016/J.Biopsych.2012.05.011 |
0.433 |
|
| 2012 |
Krystal JH. Enhancing prolonged exposure therapy for posttraumatic stress disorder with D-cycloserine: further support for treatments that promote experience-dependent neuroplasticity. Biological Psychiatry. 71: 932-4. PMID 22579302 DOI: 10.1016/J.Biopsych.2012.03.031 |
0.336 |
|
| 2012 |
Kaffman A, Krystal JH, Krystal JJ. New frontiers in animal research of psychiatric illness. Methods in Molecular Biology (Clifton, N.J.). 829: 3-30. PMID 22231804 DOI: 10.1007/978-1-61779-458-2_1 |
0.315 |
|
| 2012 |
Stone JM, Dietrich C, Edden R, Mehta MA, De Simoni S, Reed LJ, Krystal JH, Nutt D, Barker GJ. Ketamine effects on brain GABA and glutamate levels with 1H-MRS: relationship to ketamine-induced psychopathology. Molecular Psychiatry. 17: 664-5. PMID 22212598 DOI: 10.1038/Mp.2011.171 |
0.3 |
|
| 2012 |
Petrakis IL, Ralevski E, Desai N, Trevisan L, Gueorguieva R, Rounsaville B, Krystal JH. Noradrenergic vs serotonergic antidepressant with or without naltrexone for veterans with PTSD and comorbid alcohol dependence. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 37: 996-1004. PMID 22089316 DOI: 10.1038/Npp.2011.283 |
0.315 |
|
| 2012 |
Gunduz-Bruce H, Reinhart RM, Roach BJ, Gueorguieva R, Oliver S, D'Souza DC, Ford JM, Krystal JH, Mathalon DH. Glutamatergic modulation of auditory information processing in the human brain. Biological Psychiatry. 71: 969-77. PMID 22036036 DOI: 10.1016/J.Biopsych.2011.09.031 |
0.321 |
|
| 2012 |
Gomez R, Behar KL, Watzl J, Weinzimer SA, Gulanski B, Sanacora G, Koretski J, Guidone E, Jiang L, Petrakis IL, Pittman B, Krystal JH, Mason GF. Intravenous ethanol infusion decreases human cortical γ-aminobutyric acid and N-acetylaspartate as measured with proton magnetic resonance spectroscopy at 4 tesla. Biological Psychiatry. 71: 239-46. PMID 21855054 DOI: 10.1016/J.Biopsych.2011.06.026 |
0.515 |
|
| 2011 |
Gueorguieva R, Mallinckrodt C, Krystal JH. Trajectories of depression severity in clinical trials of duloxetine: insights into antidepressant and placebo responses. Archives of General Psychiatry. 68: 1227-37. PMID 22147842 DOI: 10.1001/Archgenpsychiatry.2011.132 |
0.304 |
|
| 2011 |
Marder SR, Roth B, Sullivan PF, Scolnick EM, Nestler EJ, Geyer MA, Welnberger DR, Karayiorgou M, Guidotti A, Gingrich J, Akbarian S, Buchanan RW, Lieberman JA, Conn PJ, Haggarty SJ, ... ... Krystal JH, et al. Advancing drug discovery for schizophrenia. Annals of the New York Academy of Sciences. 1236: 30-43. PMID 22032400 DOI: 10.1111/J.1749-6632.2011.06216.X |
0.463 |
|
| 2011 |
Murrough JW, Czermak C, Henry S, Nabulsi N, Gallezot JD, Gueorguieva R, Planeta-Wilson B, Krystal JH, Neumaier JF, Huang Y, Ding YS, Carson RE, Neumeister A. The effect of early trauma exposure on serotonin type 1B receptor expression revealed by reduced selective radioligand binding. Archives of General Psychiatry. 68: 892-900. PMID 21893657 DOI: 10.1001/Archgenpsychiatry.2011.91 |
0.311 |
|
| 2011 |
Murrough JW, Huang Y, Hu J, Henry S, Williams W, Gallezot JD, Bailey CR, Krystal JH, Carson RE, Neumeister A. Reduced amygdala serotonin transporter binding in posttraumatic stress disorder. Biological Psychiatry. 70: 1033-8. PMID 21855859 DOI: 10.1016/J.Biopsych.2011.07.003 |
0.323 |
|
| 2011 |
Carter CS, Barch DM, Bullmore E, Breiling J, Buchanan RW, Butler P, Cohen JD, Geyer M, Gollub R, Green MF, Jaeger J, Krystal JH, Moore H, Nuechterlein K, Robbins T, et al. Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia II: developing imaging biomarkers to enhance treatment development for schizophrenia and related disorders. Biological Psychiatry. 70: 7-12. PMID 21529781 DOI: 10.1016/J.Biopsych.2011.01.041 |
0.303 |
|
| 2011 |
Rosenheck RA, Krystal JH, Lew R, Barnett PG, Fiore L, Valley D, Thwin SS, Vertrees JE, Liang MH. Long-acting risperidone and oral antipsychotics in unstable schizophrenia. The New England Journal of Medicine. 364: 842-51. PMID 21366475 DOI: 10.1056/Nejmoa1005987 |
0.306 |
|
| 2011 |
Rosenheck RA, Krystal JH, Lew R, Barnett PG, Thwin SS, Fiore L, Valley D, Huang GD, Neal C, Vertrees JE, Liang MH. Challenges in the design and conduct of controlled clinical effectiveness trials in schizophrenia. Clinical Trials (London, England). 8: 196-204. PMID 21270143 DOI: 10.1177/1740774510392931 |
0.337 |
|
| 2011 |
Valentine GW, Mason GF, Gomez R, Fasula M, Watzl J, Pittman B, Krystal JH, Sanacora G. The antidepressant effect of ketamine is not associated with changes in occipital amino acid neurotransmitter content as measured by [(1)H]-MRS. Psychiatry Research. 191: 122-7. PMID 21232924 DOI: 10.1016/J.Pscychresns.2010.10.009 |
0.567 |
|
| 2011 |
Krystal JH, Petrakis IL, Limoncelli D, Nappi SK, Trevisan L, Pittman B, D'Souza DC, Suckow RF. Characterization of the interactive effects of glycine and D-cycloserine in men: further evidence for enhanced NMDA receptor function associated with human alcohol dependence. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 36: 701-10. PMID 21124304 DOI: 10.1038/Npp.2010.203 |
0.3 |
|
| 2011 |
Hallak JE, Dursun SM, Bosi DC, de Macedo LR, Machado-de-Sousa JP, Abrão J, Crippa JA, McGuire P, Krystal JH, Baker GB, Zuardi AW. The interplay of cannabinoid and NMDA glutamate receptor systems in humans: preliminary evidence of interactive effects of cannabidiol and ketamine in healthy human subjects. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 35: 198-202. PMID 21062637 DOI: 10.1016/J.Pnpbp.2010.11.002 |
0.343 |
|
| 2011 |
Larkin G, Beautrais A, Turelli R, Sanacora G, Powsner S, Lippmann M, Krystal J. A preliminary naturalistic study of low-dose ketamine for depression and suicide ideation in the emergency department European Psychiatry. 26: 1607-1607. DOI: 10.1016/S0924-9338(11)73311-9 |
0.553 |
|
| 2010 |
Sewell RA, Perry EB, Karper LP, Bell MD, Lysaker P, Goulet JL, Brenner L, Erdos J, d'Souza DC, Seibyl JP, Krystal JH. Clinical significance of neurological soft signs in schizophrenia: factor analysis of the Neurological Evaluation Scale. Schizophrenia Research. 124: 1-12. PMID 20855185 DOI: 10.1016/J.Schres.2010.08.036 |
0.321 |
|
| 2010 |
Krystal JH, Mathew SJ, D'Souza DC, Garakani A, Gunduz-Bruce H, Charney DS. Potential psychiatric applications of metabotropic glutamate receptor agonists and antagonists. Cns Drugs. 24: 669-93. PMID 20658799 DOI: 10.2165/11533230-000000000-00000 |
0.517 |
|
| 2010 |
Sen S, Kranzler HR, Krystal JH, Speller H, Chan G, Gelernter J, Guille C. A prospective cohort study investigating factors associated with depression during medical internship. Archives of General Psychiatry. 67: 557-65. PMID 20368500 DOI: 10.1001/Archgenpsychiatry.2010.41 |
0.304 |
|
| 2010 |
Aikins DE, Anticevic A, Kiehl KA, Krystal JH. Sex-related differences in amygdala activity influences immediate memory. Neuroreport. 21: 273-6. PMID 20093991 DOI: 10.1097/Wnr.0B013E328335B3F9 |
0.516 |
|
| 2010 |
Landeros-Weisenberger A, Bloch MH, Kelmendi B, Wegner R, Nudel J, Dombrowski P, Pittenger C, Krystal JH, Goodman WK, Leckman JF, Coric V. Dimensional predictors of response to SRI pharmacotherapy in obsessive-compulsive disorder. Journal of Affective Disorders. 121: 175-9. PMID 19577308 DOI: 10.1016/J.Jad.2009.06.010 |
0.327 |
|
| 2010 |
Larkin G, Beautrais A, Powsner S, Sanacora G, Krystal J, Turelli R, Lippmann M. 157: A Prospective Open Label Trial of Low Dose Ketamine for Acute Suicidal States In the Emergency Department Annals of Emergency Medicine. 56: S53. DOI: 10.1016/J.ANNEMERGMED.2010.06.204 |
0.445 |
|
| 2010 |
Krystal JH, Tolin DF, Sanacora G, Castner SA, Williams GV, Aikins DE, Hoffman RE, D'Souza DC. Neuroplasticity as a target of the pharmacotherapy of anxiety disorders, mood disorders and schizophrenia | Neuroplastyczność jako cel dla farmakoterapii zaburzeń lȩkowych, zaburzeń nastroju i schizofrenii Wiadomosci Psychiatryczne. 13: 163-173. |
0.515 |
|
| 2009 |
Zuo L, Luo X, Kranzler HR, Lu L, Rosenheck RA, Cramer J, van Kammen DP, Erdos J, Charney DS, Krystal J, Gelernter J. Association study of DTNBP1 with schizophrenia in a US sample. Psychiatric Genetics. 19: 292-304. PMID 19862852 DOI: 10.1097/Ypg.0B013E32832A50Bc |
0.459 |
|
| 2009 |
Krystal JH, Tolin DF, Sanacora G, Castner SA, Williams GV, Aikins DE, Hoffman RE, D'Souza DC. Neuroplasticity as a target for the pharmacotherapy of anxiety disorders, mood disorders, and schizophrenia. Drug Discovery Today. 14: 690-7. PMID 19460458 DOI: 10.1016/J.Drudis.2009.05.002 |
0.572 |
|
| 2009 |
Zuo L, Luo X, Krystal JH, Cramer J, Charney DS, Gelernter J. The efficacies of clozapine and haloperidol in refractory schizophrenia are related to DTNBP1 variation. Pharmacogenetics and Genomics. 19: 437-46. PMID 19369910 DOI: 10.1097/Fpc.0B013E32832B9Cfc |
0.468 |
|
| 2009 |
Krystal JH, Neumeister A. Noradrenergic and serotonergic mechanisms in the neurobiology of posttraumatic stress disorder and resilience. Brain Research. 1293: 13-23. PMID 19332037 DOI: 10.1016/J.Brainres.2009.03.044 |
0.316 |
|
| 2009 |
Zuo L, Luo X, Listman JB, Kranzler HR, Wang S, Anton RF, Blumberg HP, Stein MB, Pearlson GD, Covault J, Charney DS, van Kammen DP, Price LH, Lappalainen J, Cramer J, ... Krystal JH, et al. Population admixture modulates risk for alcohol dependence. Human Genetics. 125: 605-13. PMID 19306106 DOI: 10.1007/S00439-009-0647-4 |
0.466 |
|
| 2008 |
Perepletchikova F, Krystal JH, Kaufman J. Practitioner review: adolescent alcohol use disorders: assessment and treatment issues. Journal of Child Psychology and Psychiatry, and Allied Disciplines. 49: 1131-54. PMID 19017028 DOI: 10.1111/J.1469-7610.2008.01934.X |
0.302 |
|
| 2008 |
Driesen NR, Leung HC, Calhoun VD, Constable RT, Gueorguieva R, Hoffman R, Skudlarski P, Goldman-Rakic PS, Krystal JH. Impairment of working memory maintenance and response in schizophrenia: functional magnetic resonance imaging evidence. Biological Psychiatry. 64: 1026-34. PMID 18823880 DOI: 10.1016/J.Biopsych.2008.07.029 |
0.315 |
|
| 2008 |
Pittenger C, Coric V, Banasr M, Bloch M, Krystal JH, Sanacora G. Riluzole in the treatment of mood and anxiety disorders. Cns Drugs. 22: 761-86. PMID 18698875 DOI: 10.2165/00023210-200822090-00004 |
0.586 |
|
| 2008 |
Krystal JH. Capitalizing on extrasynaptic glutamate neurotransmission to treat antipsychotic-resistant symptoms in schizophrenia. Biological Psychiatry. 64: 358-60. PMID 18694665 DOI: 10.1016/J.Biopsych.2008.06.011 |
0.309 |
|
| 2008 |
Sanacora G, Zarate CA, Krystal JH, Manji HK. Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders. Nature Reviews. Drug Discovery. 7: 426-37. PMID 18425072 DOI: 10.1038/Nrd2462 |
0.564 |
|
| 2008 |
Krystal JH, Carter CS, Geschwind D, Manji HK, March JS, Nestler EJ, Zubieta JK, Charney DS, Goldman D, Gur RE, Lieberman JA, Roy-Byrne P, Rubinow DR, Anderson SA, Barondes S, et al. It is time to take a stand for medical research and against terrorism targeting medical scientists. Biological Psychiatry. 63: 725-7. PMID 18371494 DOI: 10.1016/J.Biopsych.2008.03.005 |
0.664 |
|
| 2008 |
Stone JM, Erlandsson K, Arstad E, Squassante L, Teneggi V, Bressan RA, Krystal JH, Ell PJ, Pilowsky LS. Relationship between ketamine-induced psychotic symptoms and NMDA receptor occupancy: a [(123)I]CNS-1261 SPET study. Psychopharmacology. 197: 401-8. PMID 18176855 DOI: 10.1007/S00213-007-1047-X |
0.325 |
|
| 2008 |
Krystal JH, Gueorguieva R, Cramer J, Collins J, Rosenheck R. Naltrexone is associated with reduced drinking by alcohol dependent patients receiving antidepressants for mood and anxiety symptoms: results from VA Cooperative Study No. 425, "Naltrexone in the treatment of alcoholism". Alcoholism, Clinical and Experimental Research. 32: 85-91. PMID 18070245 DOI: 10.1111/J.1530-0277.2007.00555.X |
0.326 |
|
| 2007 |
Goff DC, Keefe R, Citrome L, Davy K, Krystal JH, Large C, Thompson TR, Volavka J, Webster EL. Lamotrigine as add-on therapy in schizophrenia: results of 2 placebo-controlled trials. Journal of Clinical Psychopharmacology. 27: 582-9. PMID 18004124 DOI: 10.1097/Jcp.0B013E31815Abf34 |
0.327 |
|
| 2007 |
Krystal JH. Neuroplasticity as a target for the pharmacotherapy of psychiatric disorders: new opportunities for synergy with psychotherapy. Biological Psychiatry. 62: 833-4. PMID 17916459 DOI: 10.1016/J.Biopsych.2007.08.017 |
0.354 |
|
| 2007 |
Pittenger C, Sanacora G, Krystal JH. The NMDA receptor as a therapeutic target in major depressive disorder. Cns & Neurological Disorders Drug Targets. 6: 101-15. PMID 17430148 DOI: 10.2174/187152707780363267 |
0.572 |
|
| 2007 |
Krupitsky EM, Rudenko AA, Burakov AM, Slavina TY, Grinenko AA, Pittman B, Gueorguieva R, Petrakis IL, Zvartau EE, Krystal JH. Antiglutamatergic strategies for ethanol detoxification: comparison with placebo and diazepam. Alcoholism, Clinical and Experimental Research. 31: 604-11. PMID 17374039 DOI: 10.1111/J.1530-0277.2007.00344.X |
0.313 |
|
| 2007 |
Sanacora G, Kendell SF, Levin Y, Simen AA, Fenton LR, Coric V, Krystal JH. Preliminary evidence of riluzole efficacy in antidepressant-treated patients with residual depressive symptoms. Biological Psychiatry. 61: 822-5. PMID 17141740 DOI: 10.1016/J.Biopsych.2006.08.037 |
0.563 |
|
| 2006 |
Krystal JH, D'Souza DC, Gallinat J, Driesen N, Abi-Dargham A, Petrakis I, Heinz A, Pearlson G. The vulnerability to alcohol and substance abuse in individuals diagnosed with schizophrenia. Neurotoxicity Research. 10: 235-52. PMID 17197373 DOI: 10.1007/Bf03033360 |
0.33 |
|
| 2006 |
Neumeister A, Carson R, Henry S, Planeta-Wilson B, Binneman B, Maguire RP, Luckenbaugh DA, D'Souza C, Krystal JH, Frost JJ. Cerebral metabolic effects of intravenous glycine in healthy human subjects. Journal of Clinical Psychopharmacology. 26: 595-9. PMID 17110816 DOI: 10.1097/01.Jcp.0000245558.14284.Aa |
0.335 |
|
| 2006 |
D'Souza DC, Gil RB, Madonick S, Perry EB, Forselius-Bielen K, Braley G, Donahue L, Tellioglu T, Zimolo Z, Gueorguieva R, Krystal JH. Enhanced sensitivity to the euphoric effects of alcohol in schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 31: 2767-75. PMID 16985503 DOI: 10.1038/Sj.Npp.1301207 |
0.311 |
|
| 2006 |
Rasmusson AM, Pinna G, Paliwal P, Weisman D, Gottschalk C, Charney D, Krystal J, Guidotti A. Decreased cerebrospinal fluid allopregnanolone levels in women with posttraumatic stress disorder. Biological Psychiatry. 60: 704-13. PMID 16934764 DOI: 10.1016/J.Biopsych.2006.03.026 |
0.477 |
|
| 2006 |
Morgan CJ, Perry EB, Cho HS, Krystal JH, D'Souza DC. Greater vulnerability to the amnestic effects of ketamine in males. Psychopharmacology. 187: 405-14. PMID 16896964 DOI: 10.1007/S00213-006-0409-0 |
0.304 |
|
| 2006 |
Amin Z, Mason GF, Cavus I, Krystal JH, Rothman DL, Epperson CN. The interaction of neuroactive steroids and GABA in the development of neuropsychiatric disorders in women. Pharmacology, Biochemistry, and Behavior. 84: 635-43. PMID 16860856 DOI: 10.1016/J.Pbb.2006.06.007 |
0.318 |
|
| 2006 |
Pittenger C, Naungayan C, Kendell SF, Coric V, Malison R, Krystal JH, Sanacora GS. Visual hallucinations from the addition of riluzole to memantine and bupropion. Journal of Clinical Psychopharmacology. 26: 218-20. PMID 16633160 DOI: 10.1097/01.Jcp.0000203228.64117.9F |
0.472 |
|
| 2006 |
Pittenger C, Krystal JH, Coric V. Glutamate-modulating drugs as novel pharmacotherapeutic agents in the treatment of obsessive-compulsive disorder. Neurorx : the Journal of the American Society For Experimental Neurotherapeutics. 3: 69-81. PMID 16490414 DOI: 10.1016/J.Nurx.2005.12.006 |
0.341 |
|
| 2006 |
Blumberg HP, Krystal JH, Bansal R, Martin A, Dziura J, Durkin K, Martin L, Gerard E, Charney DS, Peterson BS. Age, rapid-cycling, and pharmacotherapy effects on ventral prefrontal cortex in bipolar disorder: a cross-sectional study. Biological Psychiatry. 59: 611-8. PMID 16414030 DOI: 10.1016/J.Biopsych.2005.08.031 |
0.459 |
|
| 2006 |
Krystal JH, Madonick S, Perry E, Gueorguieva R, Brush L, Wray Y, Belger A, D'Souza DC. Potentiation of low dose ketamine effects by naltrexone: potential implications for the pharmacotherapy of alcoholism. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 31: 1793-800. PMID 16395307 DOI: 10.1038/Sj.Npp.1300994 |
0.56 |
|
| 2006 |
Lafleur DL, Pittenger C, Kelmendi B, Gardner T, Wasylink S, Malison RT, Sanacora G, Krystal JH, Coric V. N-acetylcysteine augmentation in serotonin reuptake inhibitor refractory obsessive-compulsive disorder. Psychopharmacology. 184: 254-6. PMID 16374600 DOI: 10.1007/S00213-005-0246-6 |
0.579 |
|
| 2006 |
Sanacora G, Fenton LR, Fasula MK, Rothman DL, Levin Y, Krystal JH, Mason GF. Cortical gamma-aminobutyric acid concentrations in depressed patients receiving cognitive behavioral therapy. Biological Psychiatry. 59: 284-6. PMID 16139814 DOI: 10.1016/J.Biopsych.2005.07.015 |
0.553 |
|
| 2005 |
Cho RY, Ford JM, Krystal JH, Laruelle M, Cuthbert B, Carter CS. Functional neuroimaging and electrophysiology biomarkers for clinical trials for cognition in schizophrenia. Schizophrenia Bulletin. 31: 865-9. PMID 16166611 DOI: 10.1093/Schbul/Sbi050 |
0.306 |
|
| 2005 |
Krystal JH, Perry EB, Gueorguieva R, Belger A, Madonick SH, Abi-Dargham A, Cooper TB, Macdougall L, Abi-Saab W, D'Souza DC. Comparative and interactive human psychopharmacologic effects of ketamine and amphetamine: implications for glutamatergic and dopaminergic model psychoses and cognitive function. Archives of General Psychiatry. 62: 985-94. PMID 16143730 DOI: 10.1001/Archpsyc.62.9.985 |
0.57 |
|
| 2005 |
Coric V, Taskiran S, Pittenger C, Wasylink S, Mathalon DH, Valentine G, Saksa J, Wu YT, Gueorguieva R, Sanacora G, Malison RT, Krystal JH. Riluzole augmentation in treatment-resistant obsessive-compulsive disorder: an open-label trial. Biological Psychiatry. 58: 424-8. PMID 15993857 DOI: 10.1016/J.Biopsych.2005.04.043 |
0.565 |
|
| 2005 |
Bressan RA, Erlandsson K, Stone JM, Mulligan RS, Krystal JH, Ell PJ, Pilowsky LS. Impact of schizophrenia and chronic antipsychotic treatment on [123I]CNS-1261 binding to N-methyl-D-aspartate receptors in vivo. Biological Psychiatry. 58: 41-6. PMID 15992521 DOI: 10.1016/J.Biopsych.2005.03.016 |
0.325 |
|
| 2005 |
Kiehl KA, Stevens MC, Celone K, Kurtz M, Krystal JH. Abnormal hemodynamics in schizophrenia during an auditory oddball task. Biological Psychiatry. 57: 1029-40. PMID 15860344 DOI: 10.1016/J.Biopsych.2005.01.035 |
0.339 |
|
| 2005 |
D'Souza DC, Abi-Saab WM, Madonick S, Forselius-Bielen K, Doersch A, Braley G, Gueorguieva R, Cooper TB, Krystal JH. Delta-9-tetrahydrocannabinol effects in schizophrenia: implications for cognition, psychosis, and addiction. Biological Psychiatry. 57: 594-608. PMID 15780846 DOI: 10.1016/J.Biopsych.2004.12.006 |
0.346 |
|
| 2005 |
Kendell SF, Krystal JH, Sanacora G. GABA and glutamate systems as therapeutic targets in depression and mood disorders. Expert Opinion On Therapeutic Targets. 9: 153-68. PMID 15757488 DOI: 10.1517/14728222.9.1.153 |
0.569 |
|
| 2005 |
Cho HS, D'Souza DC, Gueorguieva R, Perry EB, Madonick S, Karper LP, Abi-Dargham A, Belger A, Abi-Saab W, Lipschitz D, Bennet A, Seibyl JP, Krystal JH. Absence of behavioral sensitization in healthy human subjects following repeated exposure to ketamine. Psychopharmacology. 179: 136-43. PMID 15682309 DOI: 10.1007/S00213-004-2066-5 |
0.553 |
|
| 2005 |
Epperson CN, O'Malley S, Czarkowski KA, Gueorguieva R, Jatlow P, Sanacora G, Rothman DL, Krystal JH, Mason GF. Sex, GABA, and nicotine: the impact of smoking on cortical GABA levels across the menstrual cycle as measured with proton magnetic resonance spectroscopy. Biological Psychiatry. 57: 44-8. PMID 15607299 DOI: 10.1016/J.Biopsych.2004.09.021 |
0.514 |
|
| 2005 |
Krystal JH, Abi-Saab W, Perry E, D'Souza DC, Liu N, Gueorguieva R, McDougall L, Hunsberger T, Belger A, Levine L, Breier A. Preliminary evidence of attenuation of the disruptive effects of the NMDA glutamate receptor antagonist, ketamine, on working memory by pretreatment with the group II metabotropic glutamate receptor agonist, LY354740, in healthy human subjects. Psychopharmacology. 179: 303-9. PMID 15309376 DOI: 10.1007/S00213-004-1982-8 |
0.56 |
|
| 2004 |
Sanacora G, Kendell SF, Fenton L, Coric V, Krystal JH. Riluzole augmentation for treatment-resistant depression. The American Journal of Psychiatry. 161: 2132. PMID 15514421 DOI: 10.1176/Appi.Ajp.161.11.2132 |
0.516 |
|
| 2004 |
Blumberg HP, Kaufman J, Martin A, Charney DS, Krystal JH, Peterson BS. Significance of adolescent neurodevelopment for the neural circuitry of bipolar disorder. Annals of the New York Academy of Sciences. 1021: 376-83. PMID 15251913 DOI: 10.1196/Annals.1308.048 |
0.463 |
|
| 2004 |
Sanacora G, Gueorguieva R, Epperson CN, Wu YT, Appel M, Rothman DL, Krystal JH, Mason GF. Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression. Archives of General Psychiatry. 61: 705-13. PMID 15237082 DOI: 10.1001/Archpsyc.61.7.705 |
0.559 |
|
| 2004 |
D'Souza DC, Perry E, MacDougall L, Ammerman Y, Cooper T, Wu YT, Braley G, Gueorguieva R, Krystal JH. The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 29: 1558-72. PMID 15173844 DOI: 10.1038/Sj.Npp.1300496 |
0.373 |
|
| 2004 |
Lappalainen J, Sanacora G, Kranzler HR, Malison R, Hibbard ES, Price LH, Krystal J, Gelernter J. Mutation screen of the glutamate decarboxylase-67 gene and haplotype association to unipolar depression. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 124: 81-6. PMID 14681921 DOI: 10.1002/Ajmg.B.20055 |
0.531 |
|
| 2004 |
Petrakis IL, O'Malley S, Rounsaville B, Poling J, McHugh-Strong C, Krystal JH. Naltrexone augmentation of neuroleptic treatment in alcohol abusing patients with schizophrenia. Psychopharmacology. 172: 291-7. PMID 14634716 DOI: 10.1007/S00213-003-1658-9 |
0.306 |
|
| 2004 |
Hoffman RE, Mathalon DH, Ford JM, Krystal JH. Cortico – (thalamo) – cortical interactions, gamma resonance, and auditory hallucinations in schizophrenia Behavioral and Brain Sciences. 27: 797-798. DOI: 10.1017/S0140525X04320182 |
0.307 |
|
| 2003 |
Kane JM, Krystal J, Correll CU. Treatment Models and Designs for Intervention Research During the Psychotic Prodrome Schizophrenia Bulletin. 29: 747-756. PMID 14989412 DOI: 10.1093/Oxfordjournals.Schbul.A007044 |
0.301 |
|
| 2003 |
Sanacora G, Rothman DL, Mason G, Krystal JH. Clinical studies implementing glutamate neurotransmission in mood disorders. Annals of the New York Academy of Sciences. 1003: 292-308. PMID 14684453 DOI: 10.1196/Annals.1300.018 |
0.56 |
|
| 2003 |
Blumberg HP, Kaufman J, Martin A, Whiteman R, Zhang JH, Gore JC, Charney DS, Krystal JH, Peterson BS. Amygdala and hippocampal volumes in adolescents and adults with bipolar disorder. Archives of General Psychiatry. 60: 1201-8. PMID 14662552 DOI: 10.1001/Archpsyc.60.12.1201 |
0.472 |
|
| 2003 |
Harvey PD, Geyer MA, Robbins TW, Krystal JH. Cognition in schizophrenia: from basic science to clinical treatment. Psychopharmacology. 169: 213-4. PMID 12955286 DOI: 10.1007/S00213-003-1581-0 |
0.303 |
|
| 2003 |
Krystal JH, D'Souza DC, Mathalon D, Perry E, Belger A, Hoffman R. NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development. Psychopharmacology. 169: 215-33. PMID 12955285 DOI: 10.1007/S00213-003-1582-Z |
0.579 |
|
| 2003 |
Krystal JH, Petrakis IL, Limoncelli D, Webb E, Gueorgueva R, D'Souza DC, Boutros NN, Trevisan L, Charney DS. Altered NMDA glutamate receptor antagonist response in recovering ethanol-dependent patients. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 28: 2020-8. PMID 12888778 DOI: 10.1038/Sj.Npp.1300252 |
0.454 |
|
| 2003 |
Blumberg HP, Martin A, Kaufman J, Leung HC, Skudlarski P, Lacadie C, Fulbright RK, Gore JC, Charney DS, Krystal JH, Peterson BS. Frontostriatal abnormalities in adolescents with bipolar disorder: preliminary observations from functional MRI. The American Journal of Psychiatry. 160: 1345-7. PMID 12832254 DOI: 10.1176/Appi.Ajp.160.7.1345 |
0.488 |
|
| 2003 |
Blumberg HP, Leung HC, Skudlarski P, Lacadie CM, Fredericks CA, Harris BC, Charney DS, Gore JC, Krystal JH, Peterson BS. A functional magnetic resonance imaging study of bipolar disorder: state- and trait-related dysfunction in ventral prefrontal cortices. Archives of General Psychiatry. 60: 601-9. PMID 12796223 DOI: 10.1001/Archpsyc.60.6.601 |
0.496 |
|
| 2003 |
Sierra M, Phillips ML, Ivin G, Krystal J, David AS. A placebo-controlled, cross-over trial of lamotrigine in depersonalization disorder. Journal of Psychopharmacology (Oxford, England). 17: 103-5. PMID 12680746 DOI: 10.1177/0269881103017001712 |
0.332 |
|
| 2003 |
Coric V, Milanovic S, Wasylink S, Patel P, Malison R, Krystal JH. Beneficial effects of the antiglutamatergic agent riluzole in a patient diagnosed with obsessive-compulsive disorder and major depressive disorder. Psychopharmacology. 167: 219-20. PMID 12658528 DOI: 10.1007/S00213-003-1396-Z |
0.323 |
|
| 2003 |
Sanacora G, Mason GF, Rothman DL, Hyder F, Ciarcia JJ, Ostroff RB, Berman RM, Krystal JH. Increased cortical GABA concentrations in depressed patients receiving ECT. The American Journal of Psychiatry. 160: 577-9. PMID 12611844 DOI: 10.1176/Appi.Ajp.160.3.577 |
0.541 |
|
| 2003 |
Rasmusson A, Guidotti A, Charney D, Vojvoda D, Lipschitz D, Weisman D, Krystal J. S.20.01 Adrenal & CSF neurosteroids as mediators of HPA axis upregulation and symptom production in premenopausal women with PTSD European Neuropsychopharmacology. 13. DOI: 10.1016/S0924-977X(03)91680-4 |
0.417 |
|
| 2003 |
Krystal J, D'Souza DH, Mathalon DH, Belger A, Perry E. S.01.03 Therapeutic implications of the NMDA receptor antagonist model psychosis European Neuropsychopharmacology. 13. DOI: 10.1016/S0924-977X(03)91600-2 |
0.528 |
|
| 2002 |
Blumberg HP, Charney DS, Krystal JH. Frontotemporal neural systems in bipolar disorder. Seminars in Clinical Neuropsychiatry. 7: 243-54. PMID 12382207 DOI: 10.1053/Scnp.2002.35220 |
0.508 |
|
| 2002 |
Lappalainen J, Kranzler HR, Malison R, Price LH, Van Dyck C, Rosenheck RA, Cramer J, Southwick S, Charney D, Krystal J, Gelernter J. A functional neuropeptide Y Leu7Pro polymorphism associated with alcohol dependence in a large population sample from the United States. Archives of General Psychiatry. 59: 825-31. PMID 12215082 DOI: 10.1001/Archpsyc.59.9.825 |
0.418 |
|
| 2002 |
Abi-Saab W, Seibyl JP, D'Souza DC, Karper LP, Gueorgueva R, Abi-Dargham A, Wong ML, Rajhans S, Erdos JP, Heninger GR, Charney DS, Krystal JH. Ritanserin antagonism of m-chlorophenylpiperazine effects in neuroleptic-free schizophrenics patients: support for serotonin-2 receptor modulation of schizophrenia symptoms. Psychopharmacology. 162: 55-62. PMID 12107618 DOI: 10.1007/S00213-002-1057-7 |
0.472 |
|
| 2002 |
Krystal JH, Anand A, Moghaddam B. Effects of NMDA receptor antagonists: implications for the pathophysiology of schizophrenia. Archives of General Psychiatry. 59: 663-4. PMID 12090822 DOI: 10.1001/Archpsyc.59.7.663 |
0.315 |
|
| 2002 |
Krystal JH, Sanacora G, Blumberg H, Anand A, Charney DS, Marek G, Epperson CN, Goddard A, Mason GF. Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments. Molecular Psychiatry. 7: S71-80. PMID 11986998 DOI: 10.1038/Sj.Mp.4001021 |
0.642 |
|
| 2002 |
Stine SM, Southwick SM, Petrakis IL, Kosten TR, Charney DS, Krystal JH. Yohimbine-induced withdrawal and anxiety symptoms in opioid-dependent patients. Biological Psychiatry. 51: 642-51. PMID 11955464 DOI: 10.1016/S0006-3223(01)01292-6 |
0.433 |
|
| 2002 |
Sanacora G, Mason GF, Rothman DL, Krystal JH. Increased occipital cortex GABA concentrations in depressed patients after therapy with selective serotonin reuptake inhibitors. The American Journal of Psychiatry. 159: 663-5. PMID 11925309 DOI: 10.1176/Appi.Ajp.159.4.663 |
0.541 |
|
| 2001 |
Krupitsky EM, Burakov AM, Romanova TN, Grinenko NI, Grinenko AY, Fletcher J, Petrakis IL, Krystal JH. Attenuation of ketamine effects by nimodipine pretreatment in recovering ethanol dependent men: psychopharmacologic implications of the interaction of NMDA and L-type calcium channel antagonists. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 25: 936-47. PMID 11750186 DOI: 10.1016/S0893-133X(01)00346-3 |
0.306 |
|
| 2001 |
Chambers RA, Krystal JH, Self DW. A neurobiological basis for substance abuse comorbidity in schizophrenia. Biological Psychiatry. 50: 71-83. PMID 11526998 DOI: 10.1016/S0006-3223(01)01134-9 |
0.341 |
|
| 2001 |
Goddard AW, Mason GF, Almai A, Rothman DL, Behar KL, Petroff OA, Charney DS, Krystal JH. Reductions in occipital cortex GABA levels in panic disorder detected with 1h-magnetic resonance spectroscopy. Archives of General Psychiatry. 58: 556-61. PMID 11386984 DOI: 10.1001/Archpsyc.58.6.556 |
0.458 |
|
| 2001 |
Stine SM, Grillon CG, Morgan CA, Kosten TR, Charney DS, Krystal JH. Methadone patients exhibit increased startle and cortisol response after intravenous yohimbine. Psychopharmacology. 154: 274-81. PMID 11351934 DOI: 10.1007/S002130000644 |
0.459 |
|
| 2001 |
Krystal JH, D'Souza DC, Sanacora G, Goddard AW, Charney DS. Current perspectives on the pathophysiology of schizophrenia, depression, and anxiety disorders. The Medical Clinics of North America. 85: 559-77. PMID 11349473 DOI: 10.1016/S0025-7125(05)70329-1 |
0.646 |
|
| 2000 |
Sanacora G, Mason GF, Krystal JH. Impairment of GABAergic transmission in depression: new insights from neuroimaging studies. Critical Reviews in Neurobiology. 14: 23-45. PMID 11253954 DOI: 10.1615/Critrevneurobiol.V14.I1.20 |
0.564 |
|
| 2000 |
Hoffman RE, Boutros NN, Hu S, Berman RM, Krystal JH, Charney DS. Transcranial magnetic stimulation and auditory hallucinations in schizophrenia. Lancet. 355: 1073-5. PMID 10744097 DOI: 10.1016/S0140-6736(00)02043-2 |
0.445 |
|
| 2000 |
Anand A, Charney DS, Oren DA, Berman RM, Hu XS, Cappiello A, Krystal JH. Attenuation of the neuropsychiatric effects of ketamine with lamotrigine: support for hyperglutamatergic effects of N-methyl-D-aspartate receptor antagonists. Archives of General Psychiatry. 57: 270-6. PMID 10711913 DOI: 10.1001/Archpsyc.57.3.270 |
0.475 |
|
| 2000 |
D'Souza DC, Gil R, Cassello K, Morrissey K, Abi-Saab D, White J, Sturwold R, Bennett A, Karper LP, Zuzarte E, Charney DS, Krystal JH. IV glycine and oral D-cycloserine effects on plasma and CSF amino acids in healthy humans. Biological Psychiatry. 47: 450-62. PMID 10704956 DOI: 10.1016/S0006-3223(99)00133-X |
0.453 |
|
| 2000 |
Laruelle M, Abi-Dargham A, van Dyck C, Gil R, D'Souza DC, Krystal J, Seibyl J, Baldwin R, Innis R. Dopamine and serotonin transporters in patients with schizophrenia: an imaging study with [(123)I]beta-CIT. Biological Psychiatry. 47: 371-9. PMID 10704949 DOI: 10.1016/S0006-3223(99)00257-7 |
0.312 |
|
| 2000 |
Berman RM, Cappiello A, Anand A, Oren DA, Heninger GR, Charney DS, Krystal JH. Antidepressant effects of ketamine in depressed patients. Biological Psychiatry. 47: 351-4. PMID 10686270 DOI: 10.1016/S0006-3223(99)00230-9 |
0.482 |
|
| 2000 |
Krystal JH, Bennett A, Abi-Saab D, Belger A, Karper LP, D'Souza DC, Lipschitz D, Abi-Dargham A, Charney DS. Dissociation of ketamine effects on rule acquisition and rule implementation: possible relevance to NMDA receptor contributions to executive cognitive functions. Biological Psychiatry. 47: 137-43. PMID 10664830 DOI: 10.1016/S0006-3223(99)00097-9 |
0.632 |
|
| 2000 |
Anand A, Berman R, Charney D, Krystal J. Attenuation of ketamine effects in healthy humans by lamotrigine, a drug that reduces glutamate release Schizophrenia Research. 41: 33. DOI: 10.1016/S0920-9964(00)90372-4 |
0.425 |
|
| 2000 |
Hoffman R, Boutros N, Berman R, Hu S, Rachid F, Schaffer N, Krystal J, Charney D. 401. One Hertz rTMS of left temporoparietal cortex in schizophrenic patients reporting auditory hallucinations Biological Psychiatry. 47: S122-S123. DOI: 10.1016/S0006-3223(00)00670-3 |
0.422 |
|
| 2000 |
Sanacora G, Mason G, Rothman D, Epperson C, Goddard A, Krystal J. 305. Reduced cortical GABA in depression is not due to decreased gray matter Biological Psychiatry. 47: S92. DOI: 10.1016/S0006-3223(00)00569-2 |
0.531 |
|
| 2000 |
Mason G, Sanacora G, Anand A, Epperson C, Goddard A, Rothman D, Charney D, Krystal J. 304. Cortical GABA reduced in unipolar but not bipolar depression Biological Psychiatry. 47: S92. DOI: 10.1016/S0006-3223(00)00568-0 |
0.538 |
|
| 2000 |
Belger A, Krystal J. 203. Working memory: constructs, neural circuits, and pharmacological modulation Biological Psychiatry. 47: S62. DOI: 10.1016/S0006-3223(00)00295-X |
0.438 |
|
| 1999 |
Verhoeff NP, Soares JC, D'Souza CD, Gil R, Degen K, Abi-Dargham A, Zoghbi SS, Fujita M, Rajeevan N, Seibyl JP, Krystal JH, van Dyck CH, Charney DS, Innis RB. [123I]Iomazenil SPECT benzodiazepine receptor imaging in schizophrenia. Psychiatry Research. 91: 163-73. PMID 10641580 DOI: 10.1016/S0925-4927(99)00027-X |
0.484 |
|
| 1999 |
Boutros NN, Belger A, Campbell D, D'Souza C, Krystal J. Comparison of four components of sensory gating in schizophrenia and normal subjects: a preliminary report. Psychiatry Research. 88: 119-30. PMID 10622348 DOI: 10.1016/S0165-1781(99)00074-8 |
0.556 |
|
| 1999 |
Sanacora G, Mason GF, Rothman DL, Behar KL, Hyder F, Petroff OA, Berman RM, Charney DS, Krystal JH. Reduced cortical gamma-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy. Archives of General Psychiatry. 56: 1043-7. PMID 10565505 DOI: 10.1001/Archpsyc.56.11.1043 |
0.612 |
|
| 1999 |
Chambers RA, Bremner JD, Moghaddam B, Southwick SM, Charney DS, Krystal JH. Glutamate and post-traumatic stress disorder: toward a psychobiology of dissociation. Seminars in Clinical Neuropsychiatry. 4: 274-81. PMID 10553033 DOI: 10.153/SCNP00400274 |
0.399 |
|
| 1999 |
Southwick SM, Paige S, Morgan CA, Bremner JD, Krystal JH, Charney DS. Neurotransmitter alterations in PTSD: catecholamines and serotonin. Seminars in Clinical Neuropsychiatry. 4: 242-8. PMID 10553029 DOI: 10.153/SCNP00400242 |
0.411 |
|
| 1999 |
D'Souza DC, Berman RM, Krystal JH, Charney DS. Symptom provocation studies in psychiatric disorders: scientific value, risks, and future. Biological Psychiatry. 46: 1060-80. PMID 10536743 DOI: 10.1016/S0006-3223(99)00209-7 |
0.474 |
|
| 1999 |
Krystal JH, D'Souza DC, Petrakis IL, Belger A, Berman RM, Charney DS, Abi-Saab W, Madonick S. NMDA agonists and antagonists as probes of glutamatergic dysfunction and pharmacotherapies in neuropsychiatric disorders. Harvard Review of Psychiatry. 7: 125-43. PMID 10483932 DOI: 10.3109/Hrp.7.3.125 |
0.641 |
|
| 1999 |
Krystal JH, D'Souza DC, Karper LP, Bennett A, Abi-Dargham A, Abi-Saab D, Cassello K, Bowers MB, Vegso S, Heninger GR, Charney DS. Interactive effects of subanesthetic ketamine and haloperidol in healthy humans. Psychopharmacology. 145: 193-204. PMID 10463321 DOI: 10.1007/S002130051049 |
0.483 |
|
| 1999 |
Delgado PL, Miller HL, Salomon RM, Licinio J, Krystal JH, Moreno FA, Heninger GR, Charney DS. Tryptophan-depletion challenge in depressed patients treated with desipramine or fluoxetine: implications for the role of serotonin in the mechanism of antidepressant action. Biological Psychiatry. 46: 212-20. PMID 10418696 DOI: 10.1016/S0006-3223(99)00014-1 |
0.362 |
|
| 1999 |
Hoffman RE, Boutros NN, Berman RM, Roessler E, Belger A, Krystal JH, Charney DS. Transcranial magnetic stimulation of left temporoparietal cortex in three patients reporting hallucinated "voices". Biological Psychiatry. 46: 130-2. PMID 10394483 DOI: 10.1016/S0006-3223(98)00358-8 |
0.596 |
|
| 1999 |
Behar KL, Rothman DL, Petersen KF, Hooten M, Delaney R, Petroff OA, Shulman GI, Navarro V, Petrakis IL, Charney DS, Krystal JH. Preliminary evidence of low cortical GABA levels in localized 1H-MR spectra of alcohol-dependent and hepatic encephalopathy patients. The American Journal of Psychiatry. 156: 952-4. PMID 10360140 DOI: 10.1176/Ajp.156.6.952 |
0.444 |
|
| 1999 |
Abi-Dargham A, Laruelle M, Krystal J, D'Souza C, Zoghbi S, Baldwin RM, Seibyl J, Mawlawi O, de Erasquin G, Charney D, Innis RB. No evidence of altered in vivo benzodiazepine receptor binding in schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 20: 650-61. PMID 10327433 DOI: 10.1016/S0893-133X(98)00107-9 |
0.488 |
|
| 1999 |
Fujita M, Woods SW, Verhoeff NP, Abi-Dargham A, Baldwin RM, Zoghbi SS, Soares JC, Jatlow PA, Krystal JH, Rajeevan N, Charney DS, Seibyl JP, Innis RB. Changes of benzodiazepine receptors during chronic benzodiazepine administration in humans. European Journal of Pharmacology. 368: 161-72. PMID 10193652 DOI: 10.1016/S0014-2999(99)00013-8 |
0.441 |
|
| 1999 |
Sanacora G, Rothman D, Krystal JH. Applications of magnetic resonance spectroscopy to psychiatry Neuroscientist. 5: 192-196. DOI: 10.1177/107385849900500316 |
0.505 |
|
| 1999 |
Sanacora G, Mason GF, Rothman DL, Berman RM, Charney DS, Ciarcia JJ, Krystal JH. 1. ECT Effects on Cortical GABA Levels as Determined by 1H-MRS The Journal of Ect. 15: 102. DOI: 10.1097/00124509-199903000-00009 |
0.581 |
|
| 1999 |
Krystal JH, Belger A, D'Souza DC, Anand A, Charney DS, Aghajanian GK, Moghaddam B. Therapeutic implications of the hyperglutamatergic effects of NMDA antagonists Neuropsychopharmacology. 21: S143-S157. DOI: 10.1016/S0893-133X(99)00102-5 |
0.64 |
|
| 1998 |
Abi-Dargham A, Krystal JH, Anjilvel S, Scanley BE, Zoghbi S, Baldwin RM, Rajeevan N, Ellis S, Petrakis IL, Seibyl JP, Charney DS, Laruelle M, Innis RB. Alterations of benzodiazepine receptors in type II alcoholic subjects measured with SPECT and [123I]iomazenil. The American Journal of Psychiatry. 155: 1550-5. PMID 9812116 DOI: 10.1176/Ajp.155.11.1550 |
0.437 |
|
| 1998 |
Abi-Saab WM, D'Souza DC, Moghaddam B, Krystal JH. The NMDA antagonist model for schizophrenia: promise and pitfalls. Pharmacopsychiatry. 31: 104-9. PMID 9754841 DOI: 10.1055/S-2007-979354 |
0.363 |
|
| 1998 |
Belger A, Puce A, Krystal JH, Gore JC, Goldman-Rakic P, McCarthy G. Dissociation of mnemonic and perceptual processes during spatial and nonspatial working memory using fMRI. Human Brain Mapping. 6: 14-32. PMID 9673660 DOI: 10.1002/(Sici)1097-0193(1998)6:1<14::Aid-Hbm2>3.0.Co;2-O |
0.508 |
|
| 1998 |
Abi-Dargham A, Gil R, Krystal J, Baldwin RM, Seibyl JP, Bowers M, van Dyck CH, Charney DS, Innis RB, Laruelle M. Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort. The American Journal of Psychiatry. 155: 761-7. PMID 9619147 DOI: 10.1176/Ajp.155.6.761 |
0.463 |
|
| 1998 |
Sernyak MJ, Glazer WM, Heninger GR, Charney DS, Woods SW, Petrakis IL, Krystal JH, Price LH. Naltrexone augmentation of neuroleptics in schizophrenia. Journal of Clinical Psychopharmacology. 18: 248-51. PMID 9617985 DOI: 10.1097/00004714-199806000-00011 |
0.488 |
|
| 1998 |
Krystal JH, Petrakis IL, Webb E, Cooney NL, Karper LP, Namanworth S, Stetson P, Trevisan LA, Charney DS. Dose-related ethanol-like effects of the NMDA antagonist, ketamine, in recently detoxified alcoholics. Archives of General Psychiatry. 55: 354-60. PMID 9554431 DOI: 10.1001/Archpsyc.55.4.354 |
0.447 |
|
| 1998 |
Krystal JH, Karper LP, Bennett A, D'Souza DC, Abi-Dargham A, Morrissey K, Abi-Saab D, Bremner JD, Bowers MB, Suckow RF, Stetson P, Heninger GR, Charney DS. Interactive effects of subanesthetic ketamine and subhypnotic lorazepam in humans. Psychopharmacology. 135: 213-29. PMID 9498724 DOI: 10.1007/s002130050503 |
0.417 |
|
| 1998 |
Bremner JD, Krystal JH, Putnam FW, Southwick SM, Marmar C, Charney DS, Mazure CM. Measurement of dissociative states with the Clinician-Administered Dissociative States Scale (CADSS). Journal of Traumatic Stress. 11: 125-36. PMID 9479681 DOI: 10.1023/A:1024465317902 |
0.456 |
|
| 1998 |
Belger A, Kirino E, McCarthy G, Gore J, Krystal J. Assessment of prefrontal activation by infrequent visual targets and non-target novel stimuli in schizophrenia: A functional MRI study Schizophrenia Research. 29: 106. DOI: 10.1016/S0920-9964(97)88567-2 |
0.53 |
|
| 1998 |
D'Souza D, Belger A, Abi-Saab W, Adams S, Gil R, Larvey K, Cassello K, Sernyak M, Krystal J. 435. Dose-response of THC effects in schizophrenics and healthy controls Biological Psychiatry. 43: S130-S131. DOI: 10.1016/S0006-3223(98)90883-6 |
0.506 |
|
| 1998 |
Hoffman R, Boutros N, Berman R, Krystal J, Charney D. 310. Transcranial magnetic stimulation and hallucinated ‘voices’ Biological Psychiatry. 43: S93. DOI: 10.1016/S0006-3223(98)90758-2 |
0.378 |
|
| 1998 |
Sanacora G, Goddard A, Gil R, D'Souza D, Abi-Saab W, Petroff O, Mattson R, Mason G, Behar K, Ciarcia J, Berman R, Charney D, Rothman D, Krystal J. 24. Quantification of cortical GABA levels in neuropsychiatric patients Biological Psychiatry. 43: S8. DOI: 10.1016/S0006-3223(98)90472-3 |
0.511 |
|
| 1997 |
Southwick SM, Krystal JH, Bremner JD, Morgan CA, Nicolaou AL, Nagy LM, Johnson DR, Heninger GR, Charney DS. Noradrenergic and serotonergic function in posttraumatic stress disorder. Archives of General Psychiatry. 54: 749-58. PMID 9283511 DOI: 10.1001/Archpsyc.1997.01830200083012 |
0.475 |
|
| 1997 |
Southwick SM, Morgan CA, Bremner AD, Grillon CG, Krystal JH, Nagy LM, Charney DS. Noradrenergic alterations in posttraumatic stress disorder. Annals of the New York Academy of Sciences. 821: 125-41. PMID 9238199 DOI: 10.1111/J.1749-6632.1997.Tb48274.X |
0.451 |
|
| 1997 |
Krystal JH, Webb E, Grillon C, Cooney N, Casal L, Morgan CA, Southwick SM, Davis M, Charney DS. Evidence of acoustic startle hyperreflexia in recently detoxified early onset male alcoholics: modulation by yohimbine and m-chlorophenylpiperazine (mCPP). Psychopharmacology. 131: 207-15. PMID 9203230 DOI: 10.1007/S002130050285 |
0.471 |
|
| 1997 |
Bremner JD, Licinio J, Darnell A, Krystal JH, Owens MJ, Southwick SM, Nemeroff CB, Charney DS. Elevated CSF corticotropin-releasing factor concentrations in posttraumatic stress disorder. The American Journal of Psychiatry. 154: 624-9. PMID 9137116 DOI: 10.1176/Ajp.154.5.624 |
0.451 |
|
| 1997 |
Bremner JD, Innis RB, Salomon RM, Staib LH, Ng CK, Miller HL, Bronen RA, Krystal JH, Duncan J, Rich D, Price LH, Malison R, Dey H, Soufer R, Charney DS. Positron emission tomography measurement of cerebral metabolic correlates of tryptophan depletion-induced depressive relapse. Archives of General Psychiatry. 54: 364-74. PMID 9107153 DOI: 10.1001/Archpsyc.1997.01830160092012 |
0.389 |
|
| 1997 |
Bremner JD, Innis RB, Ng CK, Staib LH, Salomon RM, Bronen RA, Duncan J, Southwick SM, Krystal JH, Rich D, Zubal G, Dey H, Soufer R, Charney DS. Positron emission tomography measurement of cerebral metabolic correlates of yohimbine administration in combat-related posttraumatic stress disorder. Archives of General Psychiatry. 54: 246-54. PMID 9075465 |
0.402 |
|
| 1997 |
Salomon RM, Miller HL, Krystal JH, Heninger GR, Charney DS. Lack of behavioral effects of monoamine depletion in healthy subjects. Biological Psychiatry. 41: 58-64. PMID 8988796 DOI: 10.1016/0006-3223(95)00670-2 |
0.44 |
|
| 1997 |
Abi-Dargham A, Charney DS, Krystal JH. Benzodiazepine Receptor Antagonists Cns Drugs. 8: 244-256. DOI: 10.2165/00023210-199708030-00007 |
0.417 |
|
| 1997 |
Zuzarte E, Cyril D’Souza D, Gil R, White J, AbiSaab D, Charney DS, Krystal JH. Evaluation of lorazepam blockade of M-chlorophenylpiperazine (MCPP) effects in schizophrenia Schizophrenia Research. 24: 218. DOI: 10.1016/S0920-9964(97)82626-6 |
0.443 |
|
| 1997 |
Zuzarte E, Cyril D’Souza D, Gil R, Genovese A, White J, Charney DS, Krystal JH. Dose-related ethanol effects in schizophrenic patients Schizophrenia Research. 24: 218. DOI: 10.1016/S0920-9964(97)82625-4 |
0.41 |
|
| 1997 |
Laruelle M, Abi-Dargham A, Krystal JH, Charney DS, Innis RB. In vivo evaluation of dopamine synaptic funcflon in untreated schizophrenic patients Schizophrenia Research. 24: 179. DOI: 10.1016/S0920-9964(97)82515-7 |
0.412 |
|
| 1997 |
Belger A, Taqqu Y, Krystal JH. Behavioral dissociation of working memory and selective attention functions in schizophrenia Schizophrenia Research. 24: 129-130. DOI: 10.1016/S0920-9964(97)82365-1 |
0.533 |
|
| 1997 |
Belger A, McNulty A, Krystal JH. Behavioral assessment of frontal/ cingulate attention deficits in schizophrenia Schizophrenia Research. 24: 129. DOI: 10.1016/S0920-9964(97)82364-X |
0.539 |
|
| 1996 |
Krystal JH, Deutsch DN, Charney DS. The biological basis of panic disorder. The Journal of Clinical Psychiatry. 57: 23-31; discussion 32. PMID 8917129 |
0.413 |
|
| 1996 |
Karper LP, Freeman GK, Grillon C, Morgan CA, Charney DS, Krystal JH. Preliminary evidence of an association between sensorimotor gating and distractibility in psychosis. The Journal of Neuropsychiatry and Clinical Neurosciences. 8: 60-6. PMID 8845703 DOI: 10.1176/Jnp.8.1.60 |
0.367 |
|
| 1996 |
Laruelle M, Abi-Dargham A, van Dyck CH, Gil R, D'Souza CD, Erdos J, McCance E, Rosenblatt W, Fingado C, Zoghbi SS, Baldwin RM, Seibyl JP, Krystal JH, Charney DS, Innis RB. Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. Proceedings of the National Academy of Sciences of the United States of America. 93: 9235-40. PMID 8799184 DOI: 10.1073/Pnas.93.17.9235 |
0.467 |
|
| 1996 |
Krystal JH, Compere S, Nestler EJ, Rasmussen K. Nimodipine reduction of naltrexone-precipitated locus coeruleus activation and abstinence behavior in morphine-dependent rats. Physiology & Behavior. 59: 863-6. PMID 8778878 DOI: 10.1016/0031-9384(95)02206-6 |
0.403 |
|
| 1996 |
Bremner JD, Krystal JH, Southwick SM, Charney DS. Noradrenergic mechanisms in stress and anxiety: II. Clinical studies. Synapse (New York, N.Y.). 23: 39-51. PMID 8723134 DOI: 10.1002/(SICI)1098-2396(199605)23:1<39::AID-SYN5>3.0.CO;2-I |
0.406 |
|
| 1996 |
Bremner JD, Krystal JH, Southwick SM, Charney DS. Noradrenergic mechanisms in stress and anxiety: I. Preclinical studies. Synapse (New York, N.Y.). 23: 28-38. PMID 8723133 DOI: 10.1002/(Sici)1098-2396(199605)23:1<28::Aid-Syn4>3.0.Co;2-J |
0.48 |
|
| 1996 |
Bremner JD, Krystal JH, Charney DS, Southwick SM. Neural mechanisms in dissociative amnesia for childhood abuse: relevance to the current controversy surrounding the "false memory syndrome". The American Journal of Psychiatry. 153: 71-82. PMID 8659644 DOI: 10.1176/Ajp.153.7.71 |
0.353 |
|
| 1996 |
Miller HL, Delgado PL, Salomon RM, Berman R, Krystal JH, Heninger GR, Charney DS. Clinical and biochemical effects of catecholamine depletion on antidepressant-induced remission of depression. Archives of General Psychiatry. 53: 117-28. PMID 8629887 DOI: 10.1001/Archpsyc.1996.01830020031005 |
0.452 |
|
| 1996 |
Lam RW, Zis AP, Grewal A, Delgado PL, Charney DS, Krystal JH. Effects of rapid tryptophan depletion in patients with seasonal affective disorder in remission after light therapy. Archives of General Psychiatry. 53: 41-4. PMID 8540776 DOI: 10.1001/Archpsyc.1996.01830010043007 |
0.461 |
|
| 1996 |
Krystal JH, Webb E, Cooney NL, Kranzler HR, Southwick SW, Heninger GR, Charney DS. Serotonergic and noradrenergic dysregulation in alcoholism: m-chlorophenylpiperazine and yohimbine effects in recently detoxified alcoholics and healthy comparison subjects. The American Journal of Psychiatry. 153: 83-92. PMID 8540598 DOI: 10.1176/Ajp.153.1.83 |
0.43 |
|
| 1996 |
Petrakis IL, Satel SL, Stine S, Kosten TR, Namanworth SN, Charney DS, Krystal JH. AMPT Effects on Cue-Induced Craving for Cocaine The American Journal On Addictions. 5: 313-320. DOI: 10.1111/J.1521-0391.1996.Tb00317.X |
0.406 |
|
| 1995 |
Bremner JD, Krystal JH, Southwick SM, Charney DS. Functional neuroanatomical correlates of the effects of stress on memory. Journal of Traumatic Stress. 8: 527-53. PMID 8564272 DOI: 10.1007/Bf02102888 |
0.448 |
|
| 1995 |
Stine SM, Krystal JH, Kosten TR, Charney DS. Mazindol treatment for cocaine dependence Drug and Alcohol Dependence. 39: 245-252. PMID 8556974 DOI: 10.1016/0376-8716(95)01174-4 |
0.433 |
|
| 1995 |
Salomon RM, Delgado PL, Licinio J, Krystal JH, Heninger GR, Charney DS. Effects of sleep deprivation on serotonin function in depression. Biological Psychiatry. 36: 840-6. PMID 7893848 DOI: 10.1016/0006-3223(94)90595-9 |
0.444 |
|
| 1995 |
Krystal JH, Woods SW, Kosten TR, Rosen MI, Seibyl JP, van Dyck CC, Price LH, Zubal IG, Hoffer PB, Charney DS. Opiate dependence and withdrawal: preliminary assessment using single photon emission computerized tomography (SPECT). The American Journal of Drug and Alcohol Abuse. 21: 47-63. PMID 7762544 DOI: 10.3109/00952999509095229 |
0.382 |
|
| 1995 |
Satel SL, Krystal JH, Delgado PL, Kosten TR, Charney DS. Tryptophan depletion and attenuation of cue-induced craving for cocaine. The American Journal of Psychiatry. 152: 778-83. PMID 7726319 DOI: 10.1176/Ajp.152.5.778 |
0.39 |
|
| 1995 |
Morgan CA, Grillon C, Southwick SM, Nagy LM, Davis M, Krystal JH, Charney DS. Yohimbine facilitated acoustic startle in combat veterans with post-traumatic stress disorder Psychopharmacology. 117: 466-471. PMID 7604149 DOI: 10.1007/Bf02246220 |
0.402 |
|
| 1995 |
Goddard AW, Charney DS, Germine M, Woods SW, Heninger GR, Krystal JH, Goodman WK, Price LH. Effects of tryptophan depletion on responses to yohimbine in healthy human subjects Biological Psychiatry. 38: 74-85. PMID 7578653 DOI: 10.1016/0006-3223(94)00223-P |
0.443 |
|
| 1995 |
Randall PK, Bremner JD, Krystal JH, Nagy LM, Heninger GR, Nicolaou AL, Charney DS. Effects of the benzodiazepine antagonist flumazenil in PTSD. Biological Psychiatry. 38: 319-24. PMID 7495926 DOI: 10.1016/0006-3223(94)00306-N |
0.493 |
|
| 1995 |
D'Souza DC, Charney D, Krystal J. Glycine Site Agonists of the NMDA Receptor: A Review Cns Drug Reviews. 1: 227-260. DOI: 10.1111/J.1527-3458.1995.Tb00285.X |
0.42 |
|
| 1995 |
Belger A, McCarthy G, Gore J, Puce A, Constable T, Krystal J. Evaluation of frontal and parietal association cortex contributions to attention using fMRI Schizophrenia Research. 15: 76. DOI: 10.1016/0920-9964(95)95239-6 |
0.51 |
|
| 1994 |
Krystal JH, Karper LP, Seibyl JP, Freeman GK, Delaney R, Bremner JD, Heninger GR, Bowers MB, Charney DS. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Archives of General Psychiatry. 51: 199-214. PMID 8122957 DOI: 10.1001/Archpsyc.1994.03950030035004 |
0.451 |
|
| 1994 |
Krystal JH, Webb E, Cooney N, Kranzler HR, Charney DS. Specificity of ethanollike effects elicited by serotonergic and noradrenergic mechanisms. Archives of General Psychiatry. 51: 898-911. PMID 7944878 DOI: 10.1001/Archpsyc.1994.03950110058008 |
0.454 |
|
| 1994 |
Southwick SM, Bremner D, Krystal JH, Charney DS. Psychobiologic research in post-traumatic stress disorder Psychiatric Clinics of North America. 17: 251-264. PMID 7937357 DOI: 10.1016/S0193-953X(18)30112-6 |
0.506 |
|
| 1994 |
Krystal JH, Southwick SM, Charney DS. Alcohol Dependence May Be the Missing Link between Posttraumatic Stress Disorder and Panic-Reply Archives of General Psychiatry. 51: 430. DOI: 10.1001/Archpsyc.1994.03950050090014 |
0.511 |
|
| 1993 |
Charney DS, Deutch AY, Krystal JH, Southwick SM, Davis M. Psychobiologic Mechanisms of Posttraumatic Stress Disorder Archives of General Psychiatry. 50: 294-305. PMID 8466391 DOI: 10.1001/Archpsyc.1993.01820160064008 |
0.474 |
|
| 1993 |
Southwick SM, Krystal JH, Morgan CA, Johnson D, Nagy LM, Nicolaou A, Heninger GR, Charney DS. Abnormal noradrenergic function in posttraumatic stress disorder. Archives of General Psychiatry. 50: 266-74. PMID 8466387 DOI: 10.1001/Archpsyc.1993.01820160036003 |
0.482 |
|
| 1993 |
Yehuda R, Southwick SM, Krystal JH, Bremner D, Charney DS, Mason JW. Enhanced suppression of cortisol following dexamethasone administration in posttraumatic stress disorder. The American Journal of Psychiatry. 150: 83-6. PMID 8417586 DOI: 10.1176/Ajp.150.1.83 |
0.491 |
|
| 1993 |
Licinio J, Seibyl JP, Altemus M, Charney DS, Krystal JH. Elevated CSF levels of interleukin-2 in neuroleptic-free schizophrenic patients. The American Journal of Psychiatry. 150: 1408-10. PMID 8102512 DOI: 10.1176/ajp.150.9.1408 |
0.369 |
|
| 1993 |
Krystal JH, Seibyl JP, Price LH, Woods SW, Heninger GR, Aghajanian GK, Charney DS. m-Chlorophenylpiperazine effects in neuroleptic-free schizophrenic patients. Evidence implicating serotonergic systems in the positive symptoms of schizophrenia. Archives of General Psychiatry. 50: 624-35. PMID 8102048 DOI: 10.1001/Archpsyc.1993.01820200034004 |
0.506 |
|
| 1993 |
Seibyl JP, Satel SL, Anthony D, Southwick SM, Krystal JH, Charney DS. Effects of cocaine on hospital course in schizophrenia. The Journal of Nervous and Mental Disease. 181: 31-7. PMID 8093475 DOI: 10.1097/00005053-199301000-00006 |
0.427 |
|
| 1993 |
Morgan CA, Southwick SM, Grillon C, Davis M, Krystal JH, Charney DS. Yohimbine - facilitated acoustic startle reflex in humans Psychopharmacology. 110: 342-346. PMID 7831429 DOI: 10.1007/Bf02251291 |
0.385 |
|
| 1993 |
NAGY LM, KRYSTAL JH, CHARNEY DS, MERIKANGAS KR, WOODS SW. Long-Term Outcome of Panic Disorder After Short-Term Imipramine and Behavioral Group Treatment Journal of Clinical Psychopharmacology. 13: 16???24. DOI: 10.1097/00004714-199302000-00003 |
0.451 |
|
| 1992 |
Woods SW, Nagy LM, Koleszar AS, Krystal JH, Heninger GR, Charney DS. Controlled trial of alprazolam supplementation during imipramine treatment of panic disorder Journal of Clinical Psychopharmacology. 12: 32-38. PMID 1552038 DOI: 10.1097/00001573-199202000-00006 |
0.476 |
|
| 1992 |
Krystal JH, Leaf PJ, Bruce ML, Charney DS. Effects of age and alcoholism on the prevalence of panic disorder. Acta Psychiatrica Scandinavica. 85: 77-82. PMID 1546554 DOI: 10.1111/J.1600-0447.1992.Tb01447.X |
0.387 |
|
| 1992 |
Seibyl JP, Brenner L, Krystal JH, Johnson R, Charney DS. Mazindol and cocaine addiction in schizophrenia. Biological Psychiatry. 31: 1179-81. PMID 1525287 DOI: 10.1016/0006-3223(92)90171-U |
0.43 |
|
| 1992 |
Grillon C, Ameli R, Charney DS, Krystal J, Braff D. Startle gating deficits occur across prepulse intensities in schizophrenic patients. Biological Psychiatry. 32: 939-43. PMID 1467378 DOI: 10.1016/0006-3223(92)90183-Z |
0.431 |
|
| 1992 |
Krystal JH, Price LH, Opsahl C, Ricaurte GA, Heninger GR. Chronic 3,4-methylenedioxymethamphetamine (MDMA) use: effects on mood and neuropsychological function? The American Journal of Drug and Alcohol Abuse. 18: 331-41. PMID 1357957 DOI: 10.3109/00952999209026070 |
0.304 |
|
| 1992 |
Krystal JH, McDougle CJ, Woods SW, Price LH, Heninger GR, Charney DS. Dose-response relationship for oral idazoxan effects in healthy human subjects: comparison with oral yohimbine Psychopharmacology. 108: 313-319. PMID 1355923 DOI: 10.1007/Bf02245117 |
0.449 |
|
| 1992 |
Charney DS, Woods SW, Krystal JH, Nagy LM, Heninger GR. Noradrenergic neuronal dysregulation in panic disorder: The effects of intravenous yohimbine and clonidine in panic disorder patients Acta Psychiatrica Scandinavica. 86: 273-282. PMID 1333719 DOI: 10.1111/J.1600-0447.1992.Tb03266.X |
0.477 |
|
| 1992 |
Krystal JH, McDougle CJ, Kosten TR, Price LH, Aghajanian GK, Charney DS. Baclofen-assisted detoxification from opiates. A pilot study. Journal of Substance Abuse Treatment. 9: 139-42. PMID 1324986 DOI: 10.1016/0740-5472(92)90081-X |
0.44 |
|
| 1991 |
Satel SL, Price LH, Palumbo JM, McDougle CJ, Krystal JH, Gawin F, Charney DS, Heninger GR, Kleber HD. Clinical phenomenology and neurobiology of cocaine abstinence: a prospective inpatient study. The American Journal of Psychiatry. 148: 1712-6. PMID 1957935 DOI: 10.1176/Ajp.148.12.1712 |
0.413 |
|
| 1991 |
Woods SW, Charney DS, Silver JM, Krystal JH, Heninger GR. Behavioral, biochemical, and cardiovascular responses to the benzodiazepine receptor antagonist flumazenil in panic disorder Psychiatry Research. 36: 115-127. PMID 1850142 DOI: 10.1016/0165-1781(91)90124-8 |
0.469 |
|
| 1991 |
Krystal JH, Woods SW, Hill CL, Charney DS. Characteristics of panic attack subtypes: Assessment of spontaneous panic, situational panic, sleep panic, and limited symptom attacks Comprehensive Psychiatry. 32: 474-480. PMID 1778074 DOI: 10.1016/0010-440X(91)90026-9 |
0.445 |
|
| 1991 |
Seibyl JP, Krystal JH, Price LH, Woods SW, D'Amico C, Heninger GR, Charney DS. Effects of ritanserin on the behavioral, neuroendocrine, and cardiovascular responses to meta-chlorophenylpiperazine in healthy human subjects Psychiatry Research. 38: 227-236. PMID 1754635 DOI: 10.1016/0165-1781(91)90013-F |
0.435 |
|
| 1991 |
Deutch AY, Moghaddam B, Innis RB, Krystal JH, Aghajanian GK, Bunney BS, Charney DS. Mechanisms of action of atypical antipsychotic drugs. Implications for novel therapeutic strategies for schizophrenia. Schizophrenia Research. 4: 121-56. PMID 1674882 DOI: 10.1016/0920-9964(91)90030-U |
0.451 |
|
| 1991 |
Licinio J, Krystal J, Seibyl J, Altemus M, Charney D. Elevated central levels of interleukin-2 in drug-free schizophrenic patients Schizophrenia Research. 4: 372. DOI: 10.1016/0920-9964(91)90301-7 |
0.326 |
|
| 1991 |
Krystal J, Seibyl J, Price L, Woods S, Heninger G, Charney D. MCPP effects in schizophrenic patients before and after typical and atypical neuroleptic treatment Schizophrenia Research. 4: 350. DOI: 10.1016/0920-9964(91)90266-T |
0.365 |
|
| 1991 |
Nagy LM, Krystal JH, Charney DS, Woods SW. Follow-up Study of Patients With Panic Disorder-Reply Archives of General Psychiatry. 48: 861-862. DOI: 10.1001/Archpsyc.1991.01810330085018 |
0.443 |
|
| 1990 |
Kosten TR, Krystal JH, Charney DS, Price LH, Morgan CH, Kleber HD. Opioid antagonist challenges in buprenorphine maintained patients. Drug and Alcohol Dependence. 25: 73-8. PMID 2323312 DOI: 10.1016/0376-8716(90)90144-4 |
0.43 |
|
| 1990 |
Seibyl JP, Krystal JH, Charney DS. Marijuana (cannabis) use is anecdotally said to precipitate anxiety symptoms in patients with panic disorder. Is there any research evidence to support this? Also, can marijuana use precipitate or expose paranoia in patients with an underlying bipolar disorder? Journal of Clinical Psychopharmacology. 10: 78. PMID 2307743 DOI: 10.1097/00004714-199002000-00033 |
0.48 |
|
| 1990 |
Charney DS, Woods SW, Krystal JH, Heninger GR. Serotonin function and human anxiety disorders Annals of the New York Academy of Sciences. 600: 558-573. PMID 2252335 DOI: 10.1111/J.1749-6632.1990.Tb16910.X |
0.455 |
|
| 1990 |
Price LH, Charney DS, Delgado PL, Goodman WK, Krystal JH, Woods SW, Heninger GR. Clinical studies of 5-HT function using I.V. l-Tryptophan Progress in Neuropsychopharmacology and Biological Psychiatry. 14: 459-472. PMID 2236580 DOI: 10.1016/0278-5846(90)90002-X |
0.439 |
|
| 1990 |
Charney DS, Krystal JH, Delgado PL, Heninger GR. Serotonin-specific drugs for anxiety and depressive disorders Annual Review of Medicine. 41: 437-446. PMID 2139556 DOI: 10.1146/Annurev.Me.41.020190.002253 |
0.477 |
|
| 1990 |
Rasmussen K, Beitner-Johnson DB, Krystal JH, Aghajanian GK, Nestler EJ. Opiate withdrawal and the rat locus coeruleus: behavioral, electrophysiological, and biochemical correlates. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 10: 2308-17. PMID 2115910 DOI: 10.1523/Jneurosci.10-07-02308.1990 |
0.412 |
|
| 1990 |
Goodman WK, Price LH, Delgado PL, Palumbo J, Krystal JH, Nagy LM, Rasmussen SA, Heninger GR, Charney DS. Specificity of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder. Comparison of fluvoxamine and desipramine. Archives of General Psychiatry. 47: 577-85. PMID 2112374 DOI: 10.1001/Archpsyc.1990.01810180077011 |
0.511 |
|
| 1990 |
McDougle CJ, Goodman WK, Price LH, Delgado PL, Krystal JH, Charney DS, Heninger GR. Neuroleptic addition in fluvoxamine-refractory obsessive-compulsive disorder. The American Journal of Psychiatry. 147: 652-4. PMID 1970224 DOI: 10.1176/Ajp.147.5.652 |
0.472 |
|
| 1989 |
Nagy LM, Krystal JH, Woods SW, Charney DS. Clinical and Medication Outcome After Short-term Alprazolam and Behavorial Group Treatment in Panic Disorder: 2.5-Year Naturalistic Follow-up Study Archives of General Psychiatry. 46: 993-999. PMID 2818144 DOI: 10.1001/Archpsyc.1989.01810110035005 |
0.488 |
|
| 1989 |
Seibyl JP, Krystal JH, Price LH, Charney DS. Use of yohimbine to counteract nortriptyline-induced orthostatic hypotension Journal of Clinical Psychopharmacology. 9: 67-68. PMID 2708559 DOI: 10.1097/00004714-198902000-00026 |
0.393 |
|
| 1989 |
Woods SW, Krystal JH, Heninger GR, Charney DS. Effects of alprazolam and clonidine on carbon dioxide-induced increases in anxiety ratings in healthy human subjects Life Sciences. 45: 233-242. PMID 2503670 DOI: 10.1016/0024-3205(89)90255-5 |
0.44 |
|
| 1989 |
Koster K, Woods SW, Smith EO, Zubal IG, Krystal JH, Charney DS, Hoffer PB. REGIONAL CEREBRAL BLOOD FLOW CHANGES IN PATIENTS WITH PANIC DISORDER Clinical Nuclear Medicine. 14: 234. DOI: 10.1097/00003072-198903000-00039 |
0.429 |
|
| 1989 |
Krystal JH, Kosten TR, Southwick S, Mason JW, Perry BD, Giller EL. Neurobiological aspects of PTSD: Review of clinical and preclinical studies Behavior Therapy. 20: 177-198. DOI: 10.1016/S0005-7894(89)80068-1 |
0.307 |
|
| Show low-probability matches. |